はじめに
このページでは、TPG Group Holdings (SBS) Advisors, Inc.の既知の内部者取引履歴の包括的な分析を提供します。内部者取引を次のチャートに示します。内部者とは、会社の役員、取締役、または重要な投資家のことです。一般的に、内部者が重要な非公開情報に基づいて自社の取引を行うことは一般的に違法です。これは、彼らが自分の会社で取引をすることが違法であるという意味ではありません。ただし、すべての取引をフォーム4を通じてSECに報告しなければなりません。このような制約があるにもかかわらず、学術研究によると、内部者は一般的に、自分の会社の市場を上回るパフォーマンスを発揮する傾向があります。
平均取引収益性
平均取引収益性は、過去3年間に内部者が行ったすべての公開市場での購入の平均収益率です。このリストを生成するために、10b5-1取引計画の一部としてマークされたすべての取引を除いて、内部者が行ったすべての公開市場での計画外の購入を調べます。次に、3、6、および12か月にわたるこれらの取引の平均パフォーマンスを計算し、各期間を平均して、各取引の最終的なパフォーマンス指標を生成します。最後に、内部者のパフォーマンスメトリックを計算するために、すべてのパフォーマンスメトリックを平均します。このリストには、過去2年間に少なくとも3回の取引を行った内部者のみが含まれています。
この内部者取引の収益性が 「N/A」 の場合、インサイダーは過去3年間に公開市場での購入を行っていないか、または行った取引が最近すぎて信頼できるパフォーマンス指標を計算できません。
更新頻度: 1日
内部者ポジションの報告がある企業
SECへの提出書類によると、TPG Group Holdings (SBS) Advisors, Inc.は以下の企業の保有または取引を報告しています:
チャートの見方
次のチャートは、TPG Group Holdings (SBS) Advisors, Inc.が行った各公開市場の非計画取引後の証券の株価パフォーマンスを示しています。非計画取引とは、10b5-1取引計画の一部として行われなかった取引のことです。株価のパフォーマンスは、株価の累積変化率としてグラフ化されます。たとえば、2019年1月1日に内部者取引が行われた場合、チャートには現在までの証券の日割り変化が表示されます。この間に株価が10ドルから15ドルに上昇した場合、株価の累積変化率は50%となる。価格を10ドルから20ドルに変更すると100%、10ドルから5ドルに変更すると-50%になります。
最終的には、内部者が内部者情報から利益を得るために取引のタイミングを計っているかどうかを確認するために、内部者の取引が株価の超過リターン (プラスまたはマイナス) と、どの程度密接に関連しているかを判断しようとしています。内部者がこれを行っていた状況を考えてみましょう。この状況では、 (a) 購入後のプラスのリターン、または (b) 販売後のマイナスのリターンのいずれかが期待されます。(a) の場合、購入チャートは一連の上向きの曲線を示し、各購入トランザクションの後にプラスのリターンを示します。(b) の場合、販売チャートは一連の下向きの傾斜曲線を示し、各販売取引の後にマイナスのリターンを示します。
しかし、これだけでは結論を導き出すことはできません。例えば、その企業の株価が何年にもわたって非循環的に上昇していた場合、買収後のすべてのプロットは上昇傾向にあると予想されます。同様に、長年にわたる非循環的な下落は、貿易後のプロットを下方に傾斜させます。いずれのチャートもインサイダー取引を示唆するものでありません。
最も強力な指標は、株価が非常に循環的であり、購入チャートにプラスのシグナルがあり、販売チャートにマイナスのプロットがある状況です。この状況は、財務上の利点のために取引のタイミングを計っていた内部者を強く示唆するでしょう。
内部者購入ACEL / Accel Entertainment, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却ACEL / Accel Entertainment, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入ADYX / Adynxx, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却ADYX / Adynxx, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入ALLO / Allogene Therapeutics, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却ALLO / Allogene Therapeutics, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
次の表は、自動取引プランに含まれていない直近の公開市場での売買を示しています。
調整後価格は、分割調整後価格です。調整後株式数は、分割調整後株式数です。
内部者購入AMRX / Amneal Pharmaceuticals, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却AMRX / Amneal Pharmaceuticals, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入CDNA / CareDx, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却CDNA / CareDx, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入COLL / Collegium Pharmaceutical, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却COLL / Collegium Pharmaceutical, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入CRE / Cre8 Enterprise Limited - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却CRE / Cre8 Enterprise Limited-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入GPK / Graphic Packaging Holding Company - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却GPK / Graphic Packaging Holding Company-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
次の表は、自動取引プランに含まれていない直近の公開市場での売買を示しています。
調整後価格は、分割調整後価格です。調整後株式数は、分割調整後株式数です。
内部者購入LFST / LifeStance Health Group, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却LFST / LifeStance Health Group, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
次の表は、自動取引プランに含まれていない直近の公開市場での売買を示しています。
調整後価格は、分割調整後価格です。調整後株式数は、分割調整後株式数です。
内部者購入LTH / Life Time Group Holdings, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却LTH / Life Time Group Holdings, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入MGNX / MacroGenics, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却MGNX / MacroGenics, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入MGY / Magnolia Oil & Gas Corporation - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却MGY / Magnolia Oil & Gas Corporation-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入PCVX / Vaxcyte, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却PCVX / Vaxcyte, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
次の表は、自動取引プランに含まれていない直近の公開市場での売買を示しています。
調整後価格は、分割調整後価格です。調整後株式数は、分割調整後株式数です。
内部者購入PGNY / Progyny, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却PGNY / Progyny, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
次の表は、自動取引プランに含まれていない直近の公開市場での売買を示しています。
調整後価格は、分割調整後価格です。調整後株式数は、分割調整後株式数です。
内部者購入TMHC / Taylor Morrison Home Corporation - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
次の表は、自動売買プランに含まれていない直近の公開市場買付を示しています。
調整後価格は、分割調整後価格です。調整後株式数は、分割調整後株式数です。
内部者売却TMHC / Taylor Morrison Home Corporation-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入TRTX.PRC / TPG RE Finance Trust, Inc. - Preferred Stock - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却TRTX.PRC / TPG RE Finance Trust, Inc. - Preferred Stock-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入TRVI / Trevi Therapeutics, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却TRVI / Trevi Therapeutics, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者購入VCYT / Veracyte, Inc. - 短期利益分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての計画外の公開市場内部者購入の収益性を分析します。この分析は、内部者が一貫して異常なリターンを生成しているかどうかを理解するのに役立ちます。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部者売却VCYT / Veracyte, Inc.-短期損失分析
このセクションでは、ACEL / Accel Entertainment, Inc.で行われたすべての予定外の公開市場の内部者取引の短期損失回避を分析します。損失回避の一貫したパターンは、将来の売却取引が価格の下落を予測する可能性を示唆しているかもしれません。この分析は各取引後1年間のものであり、結果は理論的なものです。
内部取引の履歴
この表は、証券取引委員会 (SEC) に開示されたTPG Group Holdings (SBS) Advisors, Inc.による内部者取引の完全なリストを示しています。
| 提出日 | 取引日 | フォーム | ティッカー | 証券 | コード | 株式数 | 残り株式数 | 変動 率 |
株式 価格 |
取引 価格 |
残り 価値 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-25 |
|
4/A | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
J - Other | 4,644 | 7,186,086 | 0.06 | 8.25 | 38,313 | 59,285,210 | |
| 2021-12-07 | 3 | VCSA |
Vacasa, Inc.
Class A Common Stock |
5,466,504 | ||||||||
| 2021-10-14 |
|
4 | MCFE |
McAfee Corp.
Class A Unit and Class B Common Stock |
C - Conversion | -267,398 | 57,607,138 | -0.46 | ||||
| 2021-10-14 |
|
4 | MCFE |
McAfee Corp.
Class A Common Stock |
S - Sale | -545,416 | 59,894,768 | -0.90 | 21.71 | -11,842,345 | 1,300,465,150 | |
| 2021-10-14 |
|
4 | MCFE |
McAfee Corp.
Class A Common Stock |
C - Conversion | 267,398 | 60,440,184 | 0.44 | ||||
| 2021-10-14 |
|
4 | LTH |
Life Time Group Holdings, Inc.
Series A Convertible Participating Preferred Stock |
C - Conversion | -2,032,318 | 0 | -100.00 | ||||
| 2021-10-14 |
|
4 | LTH |
Life Time Group Holdings, Inc.
Common Stock |
P - Purchase | 2,866,666 | 43,069,730 | 7.13 | 18.00 | 51,599,988 | 775,255,140 | |
| 2021-10-14 |
|
4 | LTH |
Life Time Group Holdings, Inc.
Common Stock |
C - Conversion | 2,503,065 | 40,203,064 | 6.64 | ||||
| 2021-10-07 | 3 | LTH |
Life Time Group Holdings, Inc.
Common Stock |
37,699,999 | ||||||||
| 2021-09-28 |
|
4 | AFTR |
AfterNext HealthTech Acquisition Corp.
Class F Ordinary Shares |
J - Other | 937,500 | 6,050,000 | 18.34 | ||||
| 2021-09-16 |
|
4 | MCFE |
McAfee Corp.
Class A Unit and Class B Common Stock |
C - Conversion | -59,097 | 57,874,536 | -0.10 | ||||
| 2021-09-16 |
|
4 | MCFE |
McAfee Corp.
Class A Common Stock |
S - Sale | -6,473,440 | 60,172,786 | -9.71 | 21.71 | -140,554,566 | 1,306,501,616 | |
| 2021-09-16 |
|
4 | MCFE |
McAfee Corp.
Class A Common Stock |
C - Conversion | 59,097 | 66,646,226 | 0.09 | ||||
| 2021-08-18 |
|
4 | AFTR |
AfterNext HealthTech Acquisition Corp.
Warrants (right to buy) |
A - Award | 4,666,667 | 4,666,667 | 1.50 | 7,000,000 | 7,000,000 | ||
| 2021-07-08 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | -897,778 | 10,000,000 | -8.24 | 60.10 | -53,956,458 | 601,000,000 | |
| 2021-07-06 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | -33,803 | 10,897,778 | -0.31 | 60.14 | -2,032,828 | 655,365,124 | |
| 2021-07-06 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | -168,929 | 10,931,581 | -1.52 | 60.42 | -10,206,640 | 660,482,845 | |
| 2021-07-01 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | -20,914 | 11,100,510 | -0.19 | 60.16 | -1,258,159 | 667,792,251 | |
| 2021-07-01 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | -500 | 11,121,424 | 0.00 | 62.08 | -31,038 | 690,373,516 | |
| 2021-07-01 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | -325,547 | 11,121,924 | -2.84 | 61.40 | -19,989,758 | 682,926,173 | |
| 2021-06-29 |
|
4 | LFST |
LifeStance Health Group, Inc.
Common Stock |
S - Sale | -4,371,905 | 175,284,635 | -2.43 | 17.01 | -74,366,104 | 2,981,591,641 | |
| 2021-06-23 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | -3,000,000 | 11,447,471 | -20.76 | 59.23 | -177,682,500 | 678,005,089 | |
| 2021-06-23 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | -277,647 | 14,447,471 | -1.89 | 64.19 | -17,823,494 | 927,452,511 | |
| 2021-06-22 |
|
4 | CNVY |
Convey Holding Parent, Inc.
Common Stock |
S - Sale | -1,666,667 | 54,699,513 | -2.96 | 13.02 | -21,700,004 | 712,187,659 | |
| 2021-06-16 | 3/A | LFHE |
LIFEHEALTHCARE, INC.
Common Stock |
0 | ||||||||
| 2021-06-16 | 3 | LFST |
LifeStance Health Group, Inc.
Common Stock |
184,902,826 | ||||||||
| 2021-06-16 |
|
4 | LFST |
LifeStance Health Group, Inc.
Common Stock |
S - Sale | -5,246,286 | 179,656,540 | -2.84 | 17.01 | -89,239,325 | 3,055,957,745 | |
| 2021-06-15 | 3 | CNVY |
Convey Holding Parent, Inc.
Common Stock |
56,366,180 | ||||||||
| 2021-06-10 | 3 | LFST |
LIFEHEALTHCARE, INC.
Common Stock |
184,902,826 | ||||||||
| 2021-06-10 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -417,902 | 9,467,556 | -4.23 | 64.59 | -26,992,248 | 611,508,495 | |
| 2021-06-10 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -260,087 | 9,885,458 | -2.56 | 65.13 | -16,940,403 | 643,875,467 | |
| 2021-06-10 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -31,486 | 10,145,545 | -0.31 | 65.95 | -2,076,599 | 669,130,144 | |
| 2021-06-10 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -28,250 | 10,177,031 | -0.28 | 62.83 | -1,774,894 | 639,403,521 | |
| 2021-06-10 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -409,905 | 10,205,281 | -3.86 | 64.07 | -26,263,146 | 653,865,621 | |
| 2021-06-10 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -480,470 | 10,615,186 | -4.33 | 65.00 | -31,230,598 | 689,988,152 | |
| 2021-06-07 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -2,500,000 | 11,095,656 | -18.39 | 62.67 | -156,671,750 | 695,350,337 | |
| 2021-03-24 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -155,802 | 13,595,656 | -1.13 | 74.19 | -11,558,717 | 1,008,641,325 | |
| 2021-03-24 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -94,075 | 13,751,458 | -0.68 | 75.45 | -7,097,507 | 1,037,481,499 | |
| 2021-03-24 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -131,217 | 13,845,533 | -0.94 | 76.49 | -10,036,303 | 1,058,993,591 | |
| 2021-03-24 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -218,906 | 13,976,750 | -1.54 | 77.41 | -16,945,886 | 1,081,963,978 | |
| 2021-03-18 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -58,274 | 14,195,656 | -0.41 | 83.18 | -4,847,394 | 1,180,834,414 | |
| 2021-03-18 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -89,798 | 14,253,930 | -0.63 | 85.77 | -7,701,831 | 1,222,536,770 | |
| 2021-03-18 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -74,436 | 14,343,728 | -0.52 | 86.36 | -6,428,181 | 1,238,702,834 | |
| 2021-03-18 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -39,453 | 14,418,164 | -0.27 | 87.33 | -3,445,525 | 1,259,172,866 | |
| 2021-03-18 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -2,200 | 14,457,617 | -0.02 | 88.14 | -193,913 | 1,274,327,615 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -321,768 | 14,459,817 | -2.18 | 86.37 | -27,792,196 | 1,248,943,558 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -121,944 | 14,781,585 | -0.82 | 87.04 | -10,614,079 | 1,286,598,027 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -31,765 | 14,903,529 | -0.21 | 88.23 | -2,802,629 | 1,314,939,854 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -12,907 | 14,935,294 | -0.09 | 89.20 | -1,151,254 | 1,332,169,977 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -9,916 | 14,948,201 | -0.07 | 90.27 | -895,147 | 1,349,418,949 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -1,700 | 14,958,117 | -0.01 | 91.67 | -155,837 | 1,371,192,636 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -32,548 | 14,959,817 | -0.22 | 83.64 | -2,722,373 | 1,251,266,022 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -17,705 | 14,992,365 | -0.12 | 84.52 | -1,496,404 | 1,267,135,200 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -19,405 | 15,010,070 | -0.13 | 85.53 | -1,659,712 | 1,283,812,788 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -2,000 | 15,029,475 | -0.01 | 86.63 | -173,264 | 1,302,036,484 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -50,705 | 15,031,475 | -0.34 | 88.05 | -4,464,347 | 1,323,453,732 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -124,897 | 15,082,180 | -0.82 | 89.17 | -11,137,028 | 1,344,873,466 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -201,061 | 15,207,077 | -1.30 | 89.84 | -18,062,335 | 1,366,129,283 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -9,470 | 15,408,138 | -0.06 | 90.44 | -856,457 | 1,393,496,593 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -49,430 | 15,417,608 | -0.32 | 86.17 | -4,259,255 | 1,328,495,196 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -114,794 | 15,467,038 | -0.74 | 86.91 | -9,977,056 | 1,344,282,034 | |
| 2021-03-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -7,141 | 15,581,832 | -0.05 | 88.03 | -628,598 | 1,371,615,693 | |
| 2021-03-11 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -36,681 | 15,588,973 | -0.23 | 85.20 | -3,125,225 | 1,328,182,058 | |
| 2021-03-11 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -17,468 | 15,625,654 | -0.11 | 86.48 | -1,510,589 | 1,351,267,494 | |
| 2021-03-11 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -43,466 | 15,643,122 | -0.28 | 87.59 | -3,807,261 | 1,370,207,649 | |
| 2021-03-11 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -18,982 | 15,686,588 | -0.12 | 88.41 | -1,678,201 | 1,386,852,814 | |
| 2021-03-11 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -2,808 | 15,705,570 | -0.02 | 89.38 | -250,985 | 1,403,799,969 | |
| 2021-03-11 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -421,759 | 15,708,378 | -2.61 | 85.29 | -35,971,867 | 1,339,769,130 | |
| 2021-03-11 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -56,443 | 16,130,137 | -0.35 | 86.44 | -4,878,702 | 1,394,222,909 | |
| 2021-03-11 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
S - Sale | -20,051 | 16,186,580 | -0.12 | 87.02 | -1,744,936 | 1,408,635,506 | |
| 2020-12-22 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -67,603 | 14,725,118 | -0.46 | 40.08 | -2,709,616 | 590,201,872 |
| 2020-12-18 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -31,063 | 14,792,721 | -0.21 | 40.07 | -1,244,552 | 592,676,284 |
| 2020-12-18 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -26,684 | 14,823,784 | -0.18 | 39.62 | -1,057,228 | 587,322,769 |
| 2020-12-18 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -43,676 | 14,850,468 | -0.29 | 41.10 | -1,794,874 | 610,282,953 |
| 2020-12-18 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -45,974 | 14,894,144 | -0.31 | 40.34 | -1,854,407 | 600,770,192 |
| 2020-12-18 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
J - Other | 2,510 | 7,183,952 | 0.03 | 8.25 | 20,708 | 59,267,604 | |
| 2020-12-17 |
|
4 | PCVX |
Vaxcyte, Inc.
Common Stock |
S - Sale | -75,703 | 5,074,574 | -1.47 | 32.46 | -2,457,456 | 164,729,806 | |
| 2020-12-17 |
|
4 | PCVX |
Vaxcyte, Inc.
Common Stock |
S - Sale | -6,276 | 5,150,277 | -0.12 | 33.02 | -207,235 | 170,063,692 | |
| 2020-12-15 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -7,633 | 14,940,118 | -0.05 | 40.04 | -305,622 | 598,194,855 |
| 2020-12-15 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -10,658 | 14,947,751 | -0.07 | 39.47 | -420,707 | 590,038,554 |
| 2020-12-15 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -21,980 | 14,958,409 | -0.15 | 38.46 | -845,313 | 575,274,981 |
| 2020-12-15 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -3,200 | 14,980,389 | -0.02 | 37.45 | -119,834 | 560,985,607 |
| 2020-12-15 |
|
4 | AI |
C3.ai, Inc.
Series G Preferred Stock |
C - Conversion | -2,522,042 | 0 | -100.00 | ||||
| 2020-12-15 |
|
4 | AI |
C3.ai, Inc.
Series F Preferred Stock |
C - Conversion | -3,825,203 | 0 | -100.00 | ||||
| 2020-12-15 |
|
4 | AI |
C3.ai, Inc.
Series E Preferred Stock |
C - Conversion | -65,591 | 0 | -100.00 | ||||
| 2020-12-15 |
|
4 | AI |
C3.ai, Inc.
Series D Preferred Stock |
C - Conversion | -8,535,475 | 0 | -100.00 | ||||
| 2020-12-15 |
|
4 | AI |
C3.ai, Inc.
Series C* Preferred Stock |
C - Conversion | -584,795 | 0 | -100.00 | ||||
| 2020-12-15 |
|
4 | AI |
C3.ai, Inc.
Class A-1 Common Stock |
C - Conversion | -673,525 | 0 | -100.00 | ||||
| 2020-12-15 |
|
4 | AI |
C3.ai, Inc.
Class A Common Stock |
C - Conversion | 16,206,631 | 16,206,631 | |||||
| 2020-12-11 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -67,908 | 14,983,589 | -0.45 | 37.57 | -2,551,073 | 562,882,495 |
| 2020-12-11 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -5,192 | 15,051,497 | -0.03 | 36.93 | -191,759 | 555,905,970 |
| 2020-12-11 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -34,483 | 15,056,689 | -0.23 | 37.74 | -1,301,444 | 568,263,534 |
| 2020-12-11 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -50,628 | 15,091,172 | -0.33 | 36.88 | -1,867,252 | 556,589,587 |
| 2020-12-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -63,318 | 15,141,800 | -0.42 | 37.86 | -2,396,985 | 573,212,523 |
| 2020-12-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -24,848 | 15,205,118 | -0.16 | 37.87 | -940,947 | 575,788,929 |
| 2020-12-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -24,782 | 15,229,966 | -0.16 | 37.34 | -925,471 | 568,755,465 |
| 2020-12-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -70,567 | 15,254,748 | -0.46 | 37.43 | -2,641,492 | 571,021,829 |
| 2020-12-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -27,297 | 15,325,315 | -0.18 | 36.89 | -1,007,052 | 565,387,651 |
| 2020-12-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -53,476 | 15,352,612 | -0.35 | 37.56 | -2,008,735 | 576,694,770 |
| 2020-12-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -74,030 | 15,406,088 | -0.48 | 36.97 | -2,736,549 | 569,492,205 |
| 2020-12-02 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -15,778 | 15,480,118 | -0.10 | 36.09 | -569,415 | 558,665,075 |
| 2020-12-02 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -59,222 | 15,495,896 | -0.38 | 35.13 | -2,080,522 | 544,384,773 |
| 2020-11-24 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -29,197 | 15,555,118 | -0.19 | 30.38 | -887,046 | 472,586,262 |
| 2020-11-24 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -6,184 | 15,584,315 | -0.04 | 29.75 | -183,988 | 463,669,215 |
| 2020-11-20 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -35,598 | 15,590,499 | -0.23 | 29.12 | -1,036,767 | 454,062,370 |
| 2020-11-20 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -15,051 | 15,626,097 | -0.10 | 28.75 | -432,704 | 449,237,788 |
| 2020-11-20 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -7,383 | 15,641,148 | -0.05 | 29.66 | -218,996 | 463,950,860 |
| 2020-11-20 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -29,137 | 15,648,531 | -0.19 | 29.19 | -850,509 | 456,780,620 |
| 2020-11-18 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -26,299 | 15,677,668 | -0.17 | 30.63 | -805,615 | 480,252,436 |
| 2020-11-18 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -16,479 | 15,703,967 | -0.10 | 29.93 | -493,269 | 470,069,985 |
| 2020-11-18 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -21,495 | 15,720,446 | -0.14 | 29.85 | -641,557 | 469,205,008 |
| 2020-11-18 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -23,177 | 15,741,941 | -0.15 | 29.13 | -675,167 | 458,576,909 |
| 2020-11-16 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -783 | 15,765,118 | 0.00 | 29.86 | -23,379 | 470,716,470 |
| 2020-11-16 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -45,357 | 15,765,901 | -0.29 | 30.15 | -1,367,441 | 475,316,690 |
| 2020-11-16 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -43,381 | 15,811,258 | -0.27 | 29.71 | -1,289,010 | 469,810,977 |
| 2020-11-13 |
|
4 | PLYA |
Playa Hotels & Resorts N.V.
Ordinary Shares |
J - Other | -6,994,564 | 2,312,102 | -75.16 | ||||
| 2020-11-12 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -55,792 | 15,854,639 | -0.35 | 29.74 | -1,659,299 | 471,529,648 |
| 2020-11-12 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -39,687 | 15,910,431 | -0.25 | 29.23 | -1,159,932 | 465,014,167 |
| 2020-11-12 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -69,797 | 15,950,118 | -0.44 | 29.66 | -2,070,249 | 473,096,450 |
| 2020-11-12 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -26,154 | 16,019,915 | -0.16 | 28.98 | -757,812 | 464,177,037 |
| 2020-11-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -71,198 | 16,046,069 | -0.44 | 27.28 | -1,942,637 | 437,816,993 |
| 2020-11-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -68,038 | 16,117,267 | -0.42 | 26.81 | -1,824,187 | 432,124,881 |
| 2020-11-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -38,783 | 16,185,305 | -0.24 | 27.30 | -1,058,900 | 441,910,619 |
| 2020-11-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -21,030 | 16,224,088 | -0.13 | 26.76 | -562,864 | 434,234,471 |
| 2020-11-02 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -5,326 | 16,245,118 | -0.03 | 24.05 | -128,101 | 390,727,578 |
| 2020-11-02 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -27,208 | 16,250,444 | -0.17 | 24.69 | -671,741 | 401,208,837 |
| 2020-11-02 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -29,898 | 16,277,652 | -0.18 | 24.09 | -720,389 | 392,208,397 |
| 2020-10-29 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -6,247 | 16,307,550 | -0.04 | 25.76 | -160,916 | 420,066,180 |
| 2020-10-29 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -43,425 | 16,313,797 | -0.27 | 24.92 | -1,082,342 | 406,611,602 |
| 2020-10-29 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -22,896 | 16,357,222 | -0.14 | 26.77 | -612,866 | 437,840,304 |
| 2020-10-28 |
|
4 | MCFE |
McAfee Corp.
Class A Unit and Class B Common Stock |
J - Other | -1,244,002 | 57,933,633 | -2.10 | 18.90 | -23,511,638 | 1,094,945,664 | |
| 2020-10-28 |
|
4 | MCFE |
McAfee Corp.
Class A Common Stock |
S - Sale | -1,293,403 | 66,587,129 | -1.91 | 18.90 | -24,445,317 | 1,258,496,738 | |
| 2020-10-23 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -26,066 | 16,380,118 | -0.16 | 27.23 | -709,683 | 445,971,645 |
| 2020-10-23 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -32,241 | 16,406,184 | -0.20 | 27.24 | -878,396 | 446,981,561 |
| 2020-10-23 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -9,696 | 16,438,425 | -0.06 | 26.86 | -260,468 | 441,593,630 |
| 2020-10-23 |
|
4/A | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -41,893 | 16,448,121 | -0.25 | 27.49 | -1,151,517 | 452,111,147 |
| 2020-10-22 | 3 | MCFE |
McAfee Corp.
Class A Common Stock |
67,880,532 | ||||||||
| 2020-10-21 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -41,893 | 16,448,121 | -0.25 | 27.49 | -1,151,517 | 452,111,147 |
| 2020-10-21 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -11,012 | 16,490,014 | -0.07 | 28.16 | -310,117 | 464,386,827 |
| 2020-10-21 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -19,863 | 16,501,026 | -0.12 | 27.57 | -547,593 | 454,908,535 |
| 2020-10-19 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -46,684 | 16,520,889 | -0.28 | 27.86 | -1,300,472 | 460,220,753 |
| 2020-10-19 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -35,675 | 16,567,573 | -0.21 | 28.18 | -1,005,182 | 466,809,594 |
| 2020-10-19 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -16,870 | 16,603,248 | -0.10 | 27.52 | -464,261 | 456,919,725 |
| 2020-10-13 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -28,579 | 16,620,118 | -0.17 | 29.82 | -852,329 | 495,671,751 |
| 2020-10-13 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -11,933 | 16,648,697 | -0.07 | 29.33 | -350,037 | 488,364,553 |
| 2020-10-13 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -43,136 | 16,660,630 | -0.26 | 28.79 | -1,241,989 | 479,699,523 |
| 2020-10-13 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -53,221 | 16,703,766 | -0.32 | 28.23 | -1,502,493 | 471,567,359 |
| 2020-10-13 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -18,270 | 16,756,987 | -0.11 | 27.72 | -506,477 | 464,533,842 |
| 2020-10-08 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -28,820 | 16,775,257 | -0.17 | 28.28 | -815,125 | 474,459,626 |
| 2020-10-08 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -46,355 | 16,804,077 | -0.28 | 27.25 | -1,263,132 | 457,895,975 |
| 2020-10-08 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -17,887 | 16,850,432 | -0.11 | 29.81 | -533,181 | 502,282,732 |
| 2020-10-08 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -16,799 | 16,868,319 | -0.10 | 28.83 | -484,310 | 486,308,576 |
| 2020-10-05 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -25,430 | 16,885,118 | -0.15 | 28.90 | -734,869 | 487,941,074 |
| 2020-10-05 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -9,780 | 16,910,548 | -0.06 | 28.31 | -276,903 | 478,791,728 |
| 2020-10-05 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -23,346 | 16,920,328 | -0.14 | 29.18 | -681,309 | 493,787,624 |
| 2020-10-05 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -46,444 | 16,943,674 | -0.27 | 28.62 | -1,329,357 | 484,975,392 |
| 2020-09-29 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -7,447 | 16,990,118 | -0.04 | 28.48 | -212,062 | 483,812,299 |
| 2020-09-29 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -68,273 | 16,997,565 | -0.40 | 28.56 | -1,949,802 | 485,431,759 |
| 2020-09-29 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -6,668 | 17,065,838 | -0.04 | 27.82 | -185,532 | 474,843,290 |
| 2020-09-25 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -50,661 | 17,072,506 | -0.30 | 27.39 | -1,387,650 | 467,631,305 |
| 2020-09-25 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -10,423 | 17,123,167 | -0.06 | 26.88 | -280,178 | 460,282,715 |
| 2020-09-25 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -60,188 | 17,133,590 | -0.35 | 27.30 | -1,642,831 | 467,661,339 |
| 2020-09-25 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -29,328 | 17,193,778 | -0.17 | 26.91 | -789,152 | 462,646,740 |
| 2020-09-23 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -47,012 | 17,223,106 | -0.27 | 26.41 | -1,241,408 | 454,796,782 |
| 2020-09-23 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -66,486 | 17,270,118 | -0.38 | 25.20 | -1,675,241 | 435,153,436 |
| 2020-09-23 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 229 | 7,181,442 | 0.00 | 8.87 | 2,030 | 63,672,101 |
| 2020-09-23 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 17,199 | 7,181,213 | 0.24 | 8.78 | 151,031 | 63,061,104 |
| 2020-09-23 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 111,002 | 7,164,014 | 1.57 | 8.93 | 990,837 | 63,948,138 |
| 2020-09-21 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -11,213 | 17,336,604 | -0.06 | 27.24 | -305,433 | 472,235,224 |
| 2020-09-21 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -73,474 | 17,347,817 | -0.42 | 26.16 | -1,921,823 | 453,758,175 |
| 2020-09-21 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -2,000 | 17,421,291 | -0.01 | 28.24 | -56,477 | 491,951,126 |
| 2020-09-21 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -81,827 | 17,423,291 | -0.47 | 27.39 | -2,241,258 | 477,227,425 |
| 2020-09-18 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 1,200 | 7,053,012 | 0.02 | 9.00 | 10,800 | 63,477,108 |
| 2020-09-18 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 3,993 | 7,051,812 | 0.06 | 8.98 | 35,862 | 63,333,734 |
| 2020-09-18 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 216 | 7,047,819 | 0.00 | 9.00 | 1,944 | 63,430,371 |
| 2020-09-16 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -2,601 | 17,505,118 | -0.01 | 27.68 | -71,998 | 484,555,670 |
| 2020-09-16 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -7,686 | 17,507,719 | -0.04 | 26.64 | -204,770 | 466,438,899 |
| 2020-09-15 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 4,600 | 7,047,603 | 0.07 | 8.99 | 41,376 | 63,391,779 |
| 2020-09-15 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 88,466 | 7,043,003 | 1.27 | 8.82 | 780,403 | 62,129,851 |
| 2020-09-15 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 91,355 | 6,954,537 | 1.33 | 8.81 | 804,563 | 61,248,607 |
| 2020-09-14 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -27,983 | 17,515,405 | -0.16 | 26.59 | -744,004 | 465,694,334 |
| 2020-09-14 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -35,585 | 17,543,388 | -0.20 | 25.63 | -912,115 | 449,672,121 |
| 2020-09-14 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -9,145 | 17,578,973 | -0.05 | 28.38 | -259,569 | 498,956,296 |
| 2020-09-14 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -26,588 | 17,588,118 | -0.15 | 27.52 | -731,657 | 483,995,108 |
| 2020-09-14 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -30,412 | 17,614,706 | -0.17 | 26.93 | -818,889 | 474,302,381 |
| 2020-09-10 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 91,411 | 6,863,182 | 1.35 | 8.99 | 821,648 | 61,689,711 |
| 2020-09-10 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 58,875 | 6,771,771 | 0.88 | 8.98 | 528,886 | 60,832,173 |
| 2020-09-10 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
P - Purchase | X | 91,411 | 6,712,896 | 1.38 | 8.96 | 819,417 | 60,175,071 |
| 2020-09-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -3,900 | 17,645,118 | -0.02 | 27.47 | -107,136 | 484,725,508 |
| 2020-09-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -37,657 | 17,649,018 | -0.21 | 26.89 | -1,012,604 | 474,585,624 |
| 2020-09-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -16,422 | 17,686,675 | -0.09 | 26.25 | -431,056 | 464,252,226 |
| 2020-09-04 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -4,677 | 17,703,097 | -0.03 | 28.26 | -132,193 | 500,369,185 |
| 2020-09-04 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -35,457 | 17,707,774 | -0.20 | 27.63 | -979,730 | 489,292,357 |
| 2020-09-04 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -18,736 | 17,743,231 | -0.11 | 27.04 | -506,711 | 479,862,134 |
| 2020-09-04 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -16,329 | 17,761,967 | -0.09 | 29.17 | -476,337 | 518,137,892 |
| 2020-09-04 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -31,822 | 17,778,296 | -0.18 | 28.77 | -915,525 | 511,485,132 |
| 2020-09-01 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -21,933 | 17,810,118 | -0.12 | 28.69 | -629,280 | 510,990,096 |
| 2020-08-28 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -45,807 | 17,832,051 | -0.26 | 28.84 | -1,321,179 | 514,317,365 |
| 2020-08-28 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -24,047 | 17,877,858 | -0.13 | 28.36 | -682,028 | 507,057,172 |
| 2020-08-28 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -4,692 | 17,901,905 | -0.03 | 28.82 | -135,235 | 515,975,867 |
| 2020-08-28 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -48,521 | 17,906,597 | -0.27 | 28.24 | -1,370,354 | 505,727,066 |
| 2020-08-26 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -800 | 17,955,118 | 0.00 | 29.95 | -23,962 | 537,800,672 |
| 2020-08-26 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -6,920 | 17,955,918 | -0.04 | 28.94 | -200,233 | 519,561,670 |
| 2020-08-26 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -6,274 | 17,962,838 | -0.03 | 27.99 | -175,609 | 502,778,039 |
| 2020-08-24 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -12,594 | 17,969,112 | -0.07 | 30.71 | -386,788 | 551,869,165 |
| 2020-08-24 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -34,912 | 17,981,706 | -0.19 | 29.70 | -1,036,803 | 534,013,512 |
| 2020-08-24 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -25,252 | 18,016,618 | -0.14 | 31.30 | -790,292 | 563,851,680 |
| 2020-08-24 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -18,248 | 18,041,870 | -0.10 | 30.74 | -560,945 | 554,608,888 |
| 2020-08-17 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -12,466 | 18,060,118 | -0.07 | 29.80 | -371,461 | 538,153,590 |
| 2020-08-13 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -19,472 | 18,072,584 | -0.11 | 30.04 | -584,910 | 542,873,314 |
| 2020-08-13 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -38,978 | 18,092,056 | -0.21 | 29.57 | -1,152,560 | 534,973,050 |
| 2020-08-13 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -90,057 | 18,131,034 | -0.49 | 30.22 | -2,721,414 | 547,898,090 |
| 2020-08-13 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -81,462 | 18,221,091 | -0.45 | 29.67 | -2,416,831 | 540,586,972 |
| 2020-08-13 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -22,565 | 18,302,553 | -0.12 | 28.51 | -643,427 | 521,886,317 |
| 2020-08-10 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | X | -7,686 | 18,716,306 | -0.04 | 37.70 | -289,731 | 705,527,999 |
| 2020-08-10 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | X | -5,605 | 18,723,992 | -0.03 | 37.02 | -207,506 | 693,190,270 |
| 2020-08-10 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | X | -19,554 | 18,729,597 | -0.10 | 37.33 | -730,002 | 699,224,553 |
| 2020-08-10 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | X | -4,600 | 18,749,151 | -0.02 | 38.22 | -175,793 | 716,513,805 |
| 2020-08-10 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
J - Other | X | -962,555 | 18,753,751 | -4.88 | |||
| 2020-08-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -1,400 | 18,325,118 | -0.01 | 27.53 | -38,538 | 504,437,356 |
| 2020-08-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -97,183 | 18,326,518 | -0.53 | 27.20 | -2,643,242 | 498,455,632 |
| 2020-08-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -10,798 | 18,423,701 | -0.06 | 26.00 | -280,720 | 478,968,324 |
| 2020-08-06 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -125,619 | 18,434,499 | -0.68 | 27.26 | -3,424,311 | 502,515,225 |
| 2020-08-06 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -26,163 | 18,560,118 | -0.14 | 26.67 | -697,804 | 495,024,331 |
| 2020-08-04 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -119,079 | 18,586,281 | -0.64 | 27.00 | -3,214,978 | 501,805,425 |
| 2020-08-04 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -92,715 | 18,705,360 | -0.49 | 26.45 | -2,452,710 | 494,837,205 |
| 2020-07-31 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -45,943 | 18,798,075 | -0.24 | 26.26 | -1,206,491 | 493,648,728 |
| 2020-07-31 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -16,100 | 18,844,018 | -0.09 | 26.34 | -424,143 | 496,432,463 |
| 2020-07-29 |
|
4 | IQV |
IQVIA HOLDINGS INC.
Common Stock |
S - Sale | -2,919,051 | 0 | -100.00 | 159.12 | -464,479,395 | ||
| 2020-07-24 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -22,380 | 18,860,118 | -0.12 | 25.72 | -575,607 | 485,076,577 |
| 2020-07-22 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -28,317 | 18,882,498 | -0.15 | 26.45 | -748,891 | 499,379,760 |
| 2020-07-22 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -26,421 | 18,910,815 | -0.14 | 25.95 | -685,535 | 490,671,352 |
| 2020-07-22 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -62,882 | 18,937,236 | -0.33 | 26.11 | -1,641,994 | 494,494,788 |
| 2020-07-13 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -69,568 | 19,000,118 | -0.36 | 25.75 | -1,791,459 | 489,275,839 |
| 2020-07-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -33,412 | 19,101,372 | -0.17 | 25.71 | -859,099 | 491,140,207 |
| 2020-07-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -31,686 | 19,069,686 | -0.17 | 26.02 | -824,346 | 496,118,858 |
| 2020-07-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -31,741 | 19,134,784 | -0.17 | 26.18 | -831,059 | 500,996,482 |
| 2020-07-09 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -33,593 | 19,166,525 | -0.17 | 25.87 | -868,953 | 495,782,419 |
| 2020-07-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -43,619 | 19,200,118 | -0.23 | 26.68 | -1,163,899 | 512,322,509 |
| 2020-07-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -32,901 | 19,243,737 | -0.17 | 26.45 | -870,248 | 509,006,466 |
| 2020-07-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -33,480 | 19,276,638 | -0.17 | 26.09 | -873,396 | 502,871,583 |
| 2020-07-02 |
|
4 | FUSN |
Fusion Pharmaceuticals Inc.
Class B Preferred Shares |
C - Conversion | -4,289,296 | 0 | -100.00 | ||||
| 2020-07-02 |
|
4 | FUSN |
Fusion Pharmaceuticals Inc.
Class A Preferred Shares |
C - Conversion | -8,000,000 | 0 | -100.00 | ||||
| 2020-07-02 |
|
4 | FUSN |
Fusion Pharmaceuticals Inc.
Common Stock |
P - Purchase | 250,000 | 2,551,794 | 10.86 | 17.00 | 4,250,000 | 43,380,498 | |
| 2020-07-02 |
|
4 | FUSN |
Fusion Pharmaceuticals Inc.
Common Stock |
C - Conversion | 2,301,794 | 2,301,794 | |||||
| 2020-06-30 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -59,747 | 19,716,306 | -0.30 | 42.21 | -2,522,052 | 832,268,652 | |
| 2020-06-30 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -24,904 | 19,776,053 | -0.13 | 43.27 | -1,077,544 | 855,668,284 | |
| 2020-06-30 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -500 | 19,800,957 | 0.00 | 44.01 | -22,005 | 871,440,118 | |
| 2020-06-25 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -70,000 | 19,310,118 | -0.36 | 24.93 | -1,744,967 | 481,364,553 |
| 2020-06-25 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -72,359 | 19,801,457 | -0.36 | 44.19 | -3,197,327 | 874,966,980 | |
| 2020-06-25 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -15,269 | 19,873,816 | -0.08 | 43.93 | -670,714 | 872,987,179 | |
| 2020-06-25 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -22,213 | 19,889,085 | -0.11 | 44.31 | -984,236 | 881,265,467 | |
| 2020-06-25 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -110,012 | 19,911,298 | -0.55 | 43.91 | -4,830,374 | 874,259,299 | |
| 2020-06-22 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -42,855 | 20,021,310 | -0.21 | 43.16 | -1,849,828 | 864,215,842 | |
| 2020-06-22 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -129,570 | 20,064,165 | -0.64 | 42.72 | -5,534,894 | 857,088,962 | |
| 2020-06-22 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -47,767 | 20,193,735 | -0.24 | 42.04 | -2,008,306 | 849,021,356 | |
| 2020-06-22 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -94,600 | 20,241,502 | -0.47 | 42.14 | -3,986,595 | 853,009,281 | |
| 2020-06-18 |
|
4 | PCVX |
Vaxcyte, Inc.
Series D Preferred Stock |
C - Conversion | -747,295 | 0 | -100.00 | ||||
| 2020-06-18 |
|
4 | PCVX |
Vaxcyte, Inc.
Series C Preferred Stock |
C - Conversion | -3,471,758 | 0 | -100.00 | ||||
| 2020-06-18 |
|
4 | PCVX |
Vaxcyte, Inc.
Common Stock |
P - Purchase | 937,500 | 5,156,553 | 22.22 | 16.00 | 15,000,000 | 82,504,848 | |
| 2020-06-18 |
|
4 | PCVX |
Vaxcyte, Inc.
Common Stock |
C - Conversion | 4,219,053 | 4,219,053 | |||||
| 2020-06-17 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -87,319 | 20,336,102 | -0.43 | 42.18 | -3,683,482 | 857,862,194 | |
| 2020-06-17 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -174,511 | 20,423,421 | -0.85 | 42.20 | -7,364,678 | 861,905,128 | |
| 2020-06-17 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -129,154 | 20,597,932 | -0.62 | 42.14 | -5,442,885 | 868,050,409 | |
| 2020-06-10 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -34,316 | 19,380,118 | -0.18 | 25.00 | -858,041 | 484,582,408 |
| 2020-06-10 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -17,183 | 19,414,434 | -0.09 | 24.76 | -425,384 | 480,625,670 |
| 2020-06-10 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -82,623 | 19,431,617 | -0.42 | 24.94 | -2,060,461 | 484,587,608 |
| 2020-06-10 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -45,878 | 19,514,240 | -0.23 | 24.02 | -1,102,017 | 468,743,753 |
| 2020-06-05 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -1,818 | 20,727,086 | -0.01 | 47.11 | -85,638 | 976,363,895 | |
| 2020-06-05 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -274,080 | 20,728,904 | -1.30 | 47.13 | -12,916,815 | 976,909,715 | |
| 2020-06-05 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -213,322 | 21,002,984 | -1.01 | 47.75 | -10,185,699 | 1,002,850,480 | |
| 2020-06-03 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -6,296 | 19,560,118 | -0.03 | 25.26 | -159,005 | 493,990,780 |
| 2020-06-01 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -9,648 | 19,566,414 | -0.05 | 25.12 | -242,311 | 491,414,401 |
| 2020-05-21 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -57,134 | 19,576,062 | -0.29 | 25.89 | -1,479,125 | 506,798,796 |
| 2020-05-21 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -122,878 | 19,633,196 | -0.62 | 25.38 | -3,118,853 | 498,323,891 |
| 2020-05-21 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -59,345 | 19,756,074 | -0.30 | 27.85 | -1,652,699 | 550,186,905 |
| 2020-05-21 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -35,643 | 19,815,419 | -0.18 | 27.40 | -976,583 | 542,922,665 |
| 2020-05-18 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -56,181 | 19,851,062 | -0.28 | 25.02 | -1,405,649 | 496,673,571 |
| 2020-05-18 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -63,819 | 19,907,243 | -0.32 | 24.39 | -1,556,839 | 485,629,230 |
| 2020-05-11 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -10,476 | 19,971,062 | -0.05 | 22.86 | -239,473 | 456,522,500 |
| 2020-05-11 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -10,553 | 19,981,538 | -0.05 | 22.38 | -236,141 | 447,120,881 |
| 2020-05-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -16,329 | 19,992,091 | -0.08 | 22.35 | -365,025 | 446,911,199 |
| 2020-05-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -20,338 | 20,008,420 | -0.10 | 21.72 | -441,727 | 434,568,877 |
| 2020-05-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -3,300 | 20,028,758 | -0.02 | 21.75 | -71,775 | 435,625,486 |
| 2020-05-07 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
S - Sale | X | -64,004 | 20,032,058 | -0.32 | 22.75 | -1,455,797 | 455,637,172 |
| 2020-04-07 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Call Option (obligation to sell) |
X - Other | -1 | 0 | -100.00 | ||||
| 2020-04-07 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Common Stock |
J - Other | 564 | 4,824,883 | 0.01 | ||||
| 2020-04-07 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Common Stock |
X - Other | -1,500,000 | 4,824,319 | -23.72 | ||||
| 2020-03-06 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
J - Other | -4,004 | 6,621,485 | -0.06 | ||||
| 2020-03-06 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
J - Other | -39,009 | 6,625,489 | -0.59 | ||||
| 2020-02-18 |
|
4 | IQV |
IQVIA HOLDINGS INC.
Common Stock |
S - Sale | -2,996,172 | 2,919,051 | -50.65 | 164.30 | -492,271,060 | 479,600,079 | |
| 2020-02-03 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Class A Common Stock |
C - Conversion | -969,967 | 0 | -100.00 | ||||
| 2020-02-03 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
J - Other | -810,636 | 6,664,498 | -10.84 | ||||
| 2020-02-03 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
C - Conversion | 969,967 | 7,475,134 | 14.91 | ||||
| 2019-11-22 |
|
4 | ACEL |
Accel Entertainment, Inc.
Warrants (right to buy) |
J - Other | -2,449,077 | 2,439,812 | -50.09 | ||||
| 2019-11-22 |
|
4 | ACEL |
Accel Entertainment, Inc.
Class A-2 Common Stock |
J - Other | -1,001,895 | 998,105 | -50.09 | ||||
| 2019-11-22 |
|
4 | ACEL |
Accel Entertainment, Inc.
Class F Common Stock |
D - Sale to Issuer | -7,800,000 | 0 | -100.00 | ||||
| 2019-11-22 |
|
4 | ACEL |
Accel Entertainment, Inc.
Warrants (right to buy) |
D - Sale to Issuer | -2,444,444 | 4,888,889 | -33.33 | 1.50 | -3,666,666 | 7,333,334 | |
| 2019-11-22 |
|
4 | ACEL |
Accel Entertainment, Inc.
Class A-2 Common Stock |
A - Award | 2,000,000 | 2,000,000 | |||||
| 2019-11-22 |
|
4 | ACEL |
Accel Entertainment, Inc.
Class F Common Stock |
D - Sale to Issuer | -2,000,000 | 7,800,000 | -20.41 | ||||
| 2019-11-22 |
|
4 | ACEL |
Accel Entertainment, Inc.
Class F Common Stock |
D - Sale to Issuer | -1,250,000 | 9,800,000 | -11.31 | ||||
| 2019-11-22 |
|
4 | ACEL |
Accel Entertainment, Inc.
Class A-1 Common Stock |
A - Award | 97,848 | 3,740,931 | 2.69 | 10.22 | 1,000,007 | 38,232,315 | |
| 2019-11-22 |
|
4 | ACEL |
Accel Entertainment, Inc.
Class A-1 Common Stock |
G - Gift | -300,000 | 3,643,083 | -7.61 | ||||
| 2019-11-22 |
|
4 | ACEL |
Accel Entertainment, Inc.
Class A-1 Common Stock |
J - Other | -3,856,917 | 3,943,083 | -49.45 | ||||
| 2019-11-22 |
|
4 | ACEL |
Accel Entertainment, Inc.
Class A-1 Common Stock |
A - Award | 7,800,000 | 7,800,000 | |||||
| 2019-10-31 |
|
4 | PGNY |
Progyny, Inc.
Series B Preferred Stock |
C - Conversion | -12,312,458 | 0 | -100.00 | ||||
| 2019-10-31 |
|
4 | PGNY |
Progyny, Inc.
Series A Preferred Stock |
C - Conversion | -6,593,485 | 0 | -100.00 | ||||
| 2019-10-31 |
|
4 | PGNY |
Progyny, Inc.
Common Stock |
C - Conversion | 18,905,943 | 20,096,062 | 1,588.58 | ||||
| 2019-10-24 | 3 | PGNY |
Progyny, Inc.
Common Stock |
2,380,238 | ||||||||
| 2019-10-24 | 3 | PGNY |
Progyny, Inc.
Common Stock |
2,380,238 | ||||||||
| 2019-10-24 | 3 | PGNY |
Progyny, Inc.
Common Stock |
2,380,238 | ||||||||
| 2019-10-24 | 3 | PGNY |
Progyny, Inc.
Common Stock |
2,380,238 | ||||||||
| 2019-10-24 | 3 | PGNY |
Progyny, Inc.
Common Stock |
2,380,238 | ||||||||
| 2019-09-18 |
|
4 | STSA |
Satsuma Pharmaceuticals, Inc.
Series B Preferred Stock |
C - Conversion | -781,734 | 0 | -100.00 | ||||
| 2019-09-18 |
|
4 | STSA |
Satsuma Pharmaceuticals, Inc.
Series A Preferred Stock |
C - Conversion | -1,004,205 | 0 | -100.00 | ||||
| 2019-09-18 |
|
4 | STSA |
Satsuma Pharmaceuticals, Inc.
Common Stock |
P - Purchase | 100,000 | 1,885,939 | 5.60 | 15.00 | 1,500,000 | 28,289,085 | |
| 2019-09-18 |
|
4 | STSA |
Satsuma Pharmaceuticals, Inc.
Common Stock |
C - Conversion | 1,785,939 | 1,785,939 | |||||
| 2019-08-15 |
|
4 | MGY |
Magnolia Oil & Gas Corp
Class A Common Stock |
J - Other | -5,382,189 | 4,739,224 | -53.18 | ||||
| 2019-08-12 |
|
4 | IQV |
IQVIA HOLDINGS INC.
Common Stock |
S - Sale | -2,616,028 | 5,915,223 | -30.66 | 156.85 | -410,323,992 | 927,802,728 | |
| 2019-07-19 | 3 | AMRX |
Amneal Pharmaceuticals, Inc.
Class A Common Stock |
32,426,734 | ||||||||
| 2019-07-19 | 3 | AMRX |
Amneal Pharmaceuticals, Inc.
Class A Common Stock |
32,426,734 | ||||||||
| 2019-07-19 | 3 | AMRX |
Amneal Pharmaceuticals, Inc.
Class A Common Stock |
32,426,734 | ||||||||
| 2019-07-19 | 3 | AMRX |
Amneal Pharmaceuticals, Inc.
Class A Common Stock |
32,426,734 | ||||||||
| 2019-07-19 | 3 | AMRX |
Amneal Pharmaceuticals, Inc.
Class A Common Stock |
32,426,734 | ||||||||
| 2019-07-12 |
|
4 | MGY |
Magnolia Oil & Gas Corp
Warrants (right to buy) |
D - Sale to Issuer | -5,083,420 | 0 | -100.00 | ||||
| 2019-07-12 |
|
4 | MGY |
Magnolia Oil & Gas Corp
Class A Common Stock |
A - Award | 1,474,191 | 10,121,413 | 17.05 | ||||
| 2019-07-03 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Class A Common Stock |
J - Other | 43,012 | 969,967 | 4.64 | 19.28 | 829,271 | 18,700,964 | |
| 2019-06-04 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Call Option (obligation to sell) |
X - Other | -1 | 0 | -100.00 | ||||
| 2019-06-04 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Common Stock |
X - Other | -200,000 | 6,324,319 | -3.07 | ||||
| 2019-05-15 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
S - Sale | -1,918,755 | 21,216,306 | -8.29 | 29.38 | -56,373,022 | 623,335,070 | |
| 2019-05-13 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Call Option (obligation to sell) |
J - Other | -1 | 1 | -50.00 | ||||
| 2019-05-13 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Call Option (obligation to sell) |
J - Other | -1 | 1 | -50.00 | ||||
| 2019-05-13 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | -8,243,948 | 0 | -100.00 | ||||
| 2019-05-13 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -21,739,130 | 0 | -100.00 | ||||
| 2019-05-13 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Series A Preferred Stock |
C - Conversion | -13,164,257 | 0 | -100.00 | ||||
| 2019-05-13 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Common Stock |
J - Other | -48,681 | 6,524,319 | -0.74 | ||||
| 2019-05-13 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Common Stock |
P - Purchase | 800,000 | 6,573,000 | 13.86 | 10.00 | 8,000,000 | 65,730,000 | |
| 2019-05-13 |
|
4 | TRVI |
Trevi Therapeutics, Inc.
Common Stock |
C - Conversion | 5,773,000 | 5,773,000 | |||||
| 2019-05-13 | 3 | ADYX |
Alliqua BioMedical, Inc.
Common Stock |
2,224,580 | ||||||||
| 2019-05-13 | 3 | ADYX |
Alliqua BioMedical, Inc.
Common Stock |
2,224,580 | ||||||||
| 2019-05-13 | 3 | ADYX |
Alliqua BioMedical, Inc.
Common Stock |
2,224,580 | ||||||||
| 2019-05-13 | 3 | ADYX |
Alliqua BioMedical, Inc.
Common Stock |
2,224,580 | ||||||||
| 2019-05-13 | 3 | ADYX |
Alliqua BioMedical, Inc.
Common Stock |
2,224,580 | ||||||||
| 2019-03-12 |
|
4 | IQV |
IQVIA HOLDINGS INC.
Common Stock |
S - Sale | -4,044,480 | 8,531,251 | -32.16 | 140.80 | -569,462,784 | 1,201,200,141 | |
| 2019-03-01 |
|
4 | NXEO |
Nexeo Solutions, Inc.
Right to future deferred payment |
J - Other | -5,178,642 | 0 | -100.00 | ||||
| 2019-03-01 |
|
4 | NXEO |
Nexeo Solutions, Inc.
Common Stock |
J - Other | -31,139,517 | 0 | -100.00 | ||||
| 2018-12-21 |
|
4 | MGY |
Magnolia Oil & Gas Corp
Warrants (right to buy) |
J - Other | -4,916,580 | 5,083,420 | -49.17 | ||||
| 2018-12-21 |
|
4 | MGY |
Magnolia Oil & Gas Corp
Class A Common Stock |
J - Other | -7,910,778 | 8,647,222 | -47.78 | ||||
| 2018-12-21 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Class A Common Stock |
J - Other | -50,010 | 926,955 | -5.12 | ||||
| 2018-12-21 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Class A Common Stock |
J - Other | 16,515 | 976,965 | 1.72 | 20.17 | 333,108 | 19,705,384 | |
| 2018-12-21 |
|
4/A | TRTX |
TPG RE Finance Trust, Inc.
Class A Common Stock |
J - Other | -56,584 | 960,450 | -5.56 | ||||
| 2018-12-21 |
|
4/A | TRTX |
TPG RE Finance Trust, Inc.
Class A Common Stock |
J - Other | 751 | 1,017,034 | 0.07 | ||||
| 2018-12-06 |
|
4 | IQV |
IQVIA HOLDINGS INC.
Common Stock |
S - Sale | -3,573,545 | 12,575,731 | -22.13 | 123.72 | -442,118,987 | 1,555,869,439 | |
| 2018-10-17 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Series A Preferred Stock |
C - Conversion | -4,278,107 | 0 | -100.00 | ||||
| 2018-10-17 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
P - Purchase | 675,000 | 23,135,061 | 3.01 | 18.00 | 12,150,000 | 416,431,098 | |
| 2018-10-17 |
|
4 | ALLO |
Allogene Therapeutics, Inc.
Common Stock |
C - Conversion | 22,460,061 | 22,460,061 | |||||
| 2018-10-02 |
|
4 | ETTX |
Entasis Therapeutics Holdings Inc.
Series B-1 Preferred Stock |
C - Conversion | -15,254,237 | 0 | -100.00 | ||||
| 2018-10-02 |
|
4 | ETTX |
Entasis Therapeutics Holdings Inc.
Common Stock |
P - Purchase | 262,539 | 1,020,748 | 34.63 | 15.00 | 3,938,085 | 15,311,220 | |
| 2018-10-02 |
|
4 | ETTX |
Entasis Therapeutics Holdings Inc.
Common Stock |
J - Other | 22,285 | 758,209 | 3.03 | ||||
| 2018-10-02 |
|
4 | ETTX |
Entasis Therapeutics Holdings Inc.
Common Stock |
C - Conversion | 735,924 | 735,924 | |||||
| 2018-08-14 |
|
4 | SABR |
Sabre Corp
Common Stock |
S - Sale | -10,186,246 | 15,959,216 | -38.96 | 24.72 | -251,804,001 | 394,511,820 | |
| 2018-08-02 |
|
4 | MGY |
Magnolia Oil & Gas Corp
Class F Common Stock |
C - Conversion | -16,090,000 | 0 | -100.00 | ||||
| 2018-08-02 |
|
4 | MGY |
Magnolia Oil & Gas Corp
Class A Common Stock |
A - Award | 100,000 | 16,558,000 | 0.61 | 10.00 | 1,000,000 | 165,580,000 | |
| 2018-08-02 |
|
4 | MGY |
Magnolia Oil & Gas Corp
Class A Common Stock |
A - Award | 368,000 | 16,558,000 | 2.27 | 10.00 | 3,680,000 | 165,580,000 | |
| 2018-08-02 |
|
4 | MGY |
Magnolia Oil & Gas Corp
Class A Common Stock |
C - Conversion | 16,090,000 | 16,090,000 | |||||
| 2018-06-19 |
|
4 | IQV |
IQVIA HOLDINGS INC.
Common Stock |
S - Sale | -6,716,253 | 16,149,276 | -29.37 | 103.00 | -691,774,059 | 1,663,375,428 | |
| 2018-06-11 |
|
4 | SABR |
Sabre Corp
Common Stock |
S - Sale | -10,841,542 | 26,145,462 | -29.31 | 24.45 | -265,075,702 | 639,256,546 | |
| 2018-05-21 |
|
4 | CZR |
CAESARS ENTERTAINMENT Corp
Common Stock |
S - Sale | -24,924,255 | 29,280,680 | -45.98 | 13.03 | -324,763,043 | 381,527,260 | |
| 2018-03-22 |
|
4 | ZS |
Zscaler, Inc.
Series D Preferred Stock |
C - Conversion | -9,146,477 | 0 | -100.00 | ||||
| 2018-03-22 |
|
4 | ZS |
Zscaler, Inc.
Common Stock |
C - Conversion | 9,146,477 | 9,146,477 | |||||
| 2018-03-19 |
|
4 | SABR |
Sabre Corp
Common Stock |
S - Sale | -8,869,643 | 36,987,004 | -19.34 | 22.27 | -197,526,950 | 823,700,579 | |
| 2018-01-19 |
|
4 | TMHC |
Taylor Morrison Home Corp
Common Partnership Units and Class B Common Stock |
J - Other | -1,875,000 | 0 | -100.00 | 27.14 | -50,887,500 | ||
| 2018-01-19 |
|
4 | TMHC |
Taylor Morrison Home Corp
Common Partnership Units and Class B Common Stock |
J - Other | -8,853,462 | 1,875,000 | -82.52 | 27.14 | -240,282,959 | 50,887,500 | |
| 2018-01-19 |
|
4 | TMHC |
Taylor Morrison Home Corp
Class A Common Stock |
S - Sale | -1,499,732 | 0 | -100.00 | 27.14 | -40,702,726 | ||
| 2018-01-10 |
|
4 | TMHC |
Taylor Morrison Home Corp
Common Partnership Units and Class B Common Stock |
J - Other | -1,919,386 | 10,728,462 | -15.18 | 26.05 | -50,000,005 | 279,476,435 | |
| 2018-01-10 |
|
4 | TMHC |
Taylor Morrison Home Corp
Common Partnership Units and Class B Common Stock |
J - Other | -5,500,000 | 12,647,848 | -30.31 | 26.05 | -143,275,000 | 329,476,440 | |
| 2017-12-14 |
|
4 | TRTX |
TPG RE Finance Trust, Inc.
Class A Common Stock |
J - Other | -56,584 | 959,699 | -5.57 | ||||
| 2017-12-05 |
|
4 | CZR |
CAESARS ENTERTAINMENT Corp
Common Stock |
J - Other | -46,655,878 | 54,204,935 | -46.26 | ||||
| 2017-12-04 |
|
4 | IQV |
IQVIA HOLDINGS INC.
Common Stock |
S - Sale | -5,419,971 | 22,865,529 | -19.16 | 102.00 | -552,837,042 | 2,332,283,958 | |
| 2017-11-15 |
|
4 | TMHC |
Taylor Morrison Home Corp
Common Partnership Units and Class B Common Stock |
J - Other | -5,000,000 | 18,147,848 | -21.60 | 22.95 | -114,750,000 | 416,493,112 | |
| 2017-10-16 | 3 | CZR |
CAESARS ENTERTAINMENT Corp
Common Stock |
201,721,626 | ||||||||
| 2017-10-16 | 3 | CZR |
CAESARS ENTERTAINMENT Corp
Common Stock |
201,721,626 | ||||||||
| 2017-10-16 | 3 | CZR |
CAESARS ENTERTAINMENT Corp
Common Stock |
201,721,626 | ||||||||
| 2017-10-16 | 3 | CZR |
CAESARS ENTERTAINMENT Corp
Common Stock |
201,721,626 | ||||||||
| 2017-09-21 |
|
4 | Q |
Quintiles IMS Holdings, Inc.
Common Stock |
S - Sale | -4,877,974 | 28,285,500 | -14.71 | 94.87 | -462,773,393 | 2,683,445,385 | |
| 2017-09-01 |
|
4 | SUP |
SUPERIOR INDUSTRIES INTERNATIONAL INC
Series B Perpetual Convertible Preferred Stock |
C - Conversion | -9,798 | 0 | -100.00 | ||||
| 2017-09-01 |
|
4 | SUP |
SUPERIOR INDUSTRIES INTERNATIONAL INC
Series A Perpetual Convertible Preferred Stock |
C - Conversion | 9,798 | 150,000 | 6.99 | ||||
| 2017-08-30 |
|
4 | Q |
Quintiles IMS Holdings, Inc.
Common Stock |
S - Sale | -3,772,134 | 33,163,474 | -10.21 | 97.33 | -367,141,802 | 3,227,800,924 | |
| 2017-08-15 |
|
4 | TPGH |
TPG Pace Holdings Corp.
Class F Ordinary Shares |
J - Other | -250,000 | 11,050,000 | -2.21 | ||||
| 2017-07-19 | 3 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
13,010,334 | ||||||||
| 2017-07-19 | 3 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
13,010,334 | ||||||||
| 2017-07-19 | 3 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
13,010,334 | ||||||||
| 2017-07-19 | 3 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
13,010,334 | ||||||||
| 2017-07-19 | 3 | TRTX |
TPG RE Finance Trust, Inc.
Common Stock |
13,010,334 | ||||||||
| 2017-07-05 |
|
4 | TPGH |
TPG Pace Holdings Corp.
Warrants (right to buy) |
P - Purchase | -7,333,333 | 7,333,333 | -50.00 | 1.50 | -11,000,000 | 11,000,000 | |
| 2017-06-29 |
|
4 | TMHC |
Taylor Morrison Home Corp
Common Partnership Units and Class B Common Stock |
J - Other | -5,000,000 | 23,147,848 | -17.76 | 23.30 | -116,500,000 | 539,344,858 | |
| 2017-06-21 |
|
4 | PLYA |
Playa Hotels & Resorts N.V.
Warrants (right to buy) |
D - Sale to Issuer | -14,666,667 | 0 | -100.00 | ||||
| 2017-06-21 |
|
4 | PLYA |
Playa Hotels & Resorts N.V.
Ordinary Shares |
A - Award | 1,466,666 | 9,606,666 | 18.02 | ||||
| 2017-06-20 |
|
4 | TPGE |
TPG Pace Energy Holdings Corp.
Class F Common Stock |
J - Other | -1,000,000 | 16,090,000 | -5.85 | ||||
| 2017-06-02 |
|
4 | Q |
Quintiles IMS Holdings, Inc.
Common Stock |
S - Sale | -5,154,936 | 36,935,608 | -12.25 | 84.01 | -433,066,173 | 3,102,960,428 | |
| 2017-05-12 |
|
4 | TPGE |
TPG Pace Energy Holdings Corp.
Warrants (right to buy) |
P - Purchase | -10,000,000 | 10,000,000 | -50.00 | 1.50 | -15,000,000 | 15,000,000 | |
| 2017-05-09 |
|
4 | TMHC |
Taylor Morrison Home Corp
Common Partnership Units and Class B Common Stock |
J - Other | -5,000,000 | 28,147,848 | -15.08 | 23.12 | -115,600,000 | 650,778,246 | |
| 2017-03-29 |
|
4 | TMHC |
Taylor Morrison Home Corp
Common Partnership Units and Class B Common Stock |
J - Other | -5,000,000 | 33,147,848 | -13.11 | 20.78 | -103,900,000 | 688,812,281 | |
| 2017-03-14 |
|
4 | PACE |
Pace Holdings Corp.
Warrants (right to buy) |
D - Sale to Issuer | -14,666,667 | 0 | -100.00 | ||||
| 2017-03-14 |
|
4 | PACE |
Pace Holdings Corp.
Warrants (right to buy) |
D - Sale to Issuer | -7,333,333 | 14,666,667 | -33.33 | ||||
| 2017-03-14 |
|
4 | PACE |
Pace Holdings Corp.
Class F Ordinary Shares |
D - Sale to Issuer | -7,340,000 | 0 | -100.00 | ||||
| 2017-03-14 |
|
4 | PACE |
Pace Holdings Corp.
Class F Ordinary Shares |
D - Sale to Issuer | -3,750,000 | 7,340,000 | -33.81 | ||||
| 2017-03-14 |
|
4 | PACE |
Pace Holdings Corp.
Warrants (right to buy) |
D - Sale to Issuer | -2,000,000 | 0 | -100.00 | ||||
| 2017-03-14 |
|
4 | PACE |
Pace Holdings Corp.
Warrants (right to buy) |
A - Award | 2,000,000 | 2,000,000 | |||||
| 2017-03-14 |
|
4 | PACE |
Pace Holdings Corp.
Class A Ordinary Shares |
D - Sale to Issuer | -800,000 | 0 | -100.00 | ||||
| 2017-03-14 |
|
4 | PACE |
Pace Holdings Corp.
Class A Ordinary Shares |
A - Award | 800,000 | 895,000 | 842.11 | 10.00 | 8,000,000 | 8,950,000 | |
| 2017-03-14 | 3 | PLYA |
Playa Hotels & Resorts N.V.
Ordinary Shares |
16,280,000 | ||||||||
| 2017-03-14 | 3 | PLYA |
Playa Hotels & Resorts N.V.
Ordinary Shares |
16,280,000 | ||||||||
| 2017-03-14 | 3 | PLYA |
Playa Hotels & Resorts N.V.
Ordinary Shares |
16,280,000 | ||||||||
| 2017-03-14 | 3 | PLYA |
Playa Hotels & Resorts N.V.
Ordinary Shares |
16,280,000 | ||||||||
| 2017-03-14 | 3 | PLYA |
Playa Hotels & Resorts N.V.
Ordinary Shares |
16,280,000 | ||||||||
| 2017-03-14 | 3 | PLYA |
Playa Hotels & Resorts N.V.
Ordinary Shares |
16,280,000 | ||||||||
| 2017-03-02 |
|
4 | Q |
Quintiles IMS Holdings, Inc.
Common Stock |
D - Sale to Issuer | -7,561,013 | 42,090,544 | -15.23 | 77.50 | -585,978,508 | 3,262,017,160 | |
| 2017-02-15 |
|
4 | ROKA |
Roka BioScience, Inc.
Series A Convertible Preferred Stock |
C - Conversion | 4,000 | 0 | -100.00 | ||||
| 2017-02-15 |
|
4 | ROKA |
Roka BioScience, Inc.
Common Stock |
C - Conversion | 571,429 | 870,357 | 191.16 | ||||
| 2017-02-08 |
|
4 | TMHC |
Taylor Morrison Home Corp
Common Partnership Units and Class B Common Stock |
J - Other | -5,447,775 | 38,147,848 | -12.50 | 18.29 | -99,626,185 | 697,628,770 | |
| 2016-11-21 |
|
4 | NXEO |
Nexeo Solutions, Inc.
Right to future deferred payment |
J - Other | -476,318 | 5,178,642 | -8.42 | ||||
| 2016-11-14 | 3 | ALBO |
ALBIREO PHARMA, INC.
Common Stock |
1,554,192 | ||||||||
| 2016-11-14 | 3 | ALBO |
ALBIREO PHARMA, INC.
Common Stock |
1,554,192 | ||||||||
| 2016-11-14 | 3 | ALBO |
ALBIREO PHARMA, INC.
Common Stock |
1,554,192 | ||||||||
| 2016-11-14 | 3 | ALBO |
ALBIREO PHARMA, INC.
Common Stock |
1,554,192 | ||||||||
| 2016-10-31 |
|
4 | ROKA |
Roka BioScience, Inc.
Warrants (right to buy) |
P - Purchase | 571,429 | 571,429 | |||||
| 2016-10-31 |
|
4 | ROKA |
Roka BioScience, Inc.
Series A Convertible Preferred Stock |
P - Purchase | 4,000 | 4,000 | |||||
| 2016-10-07 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
J - Other | -23,663,397 | 0 | -100.00 | ||||
| 2016-10-05 |
|
4 | IMS |
IMS Health Holdings, Inc.
Common Stock |
J - Other | -110,731,840 | 0 | -100.00 | ||||
| 2016-10-05 |
|
4 | Q |
Quintiles IMS Holdings, Inc.
Common Stock |
J - Other | 42,521,023 | 49,651,557 | 596.32 | ||||
| 2016-09-02 |
|
4 | NXEO |
Nexeo Solutions, Inc.
Common Stock |
J - Other | -17,500 | 124,616,376 | -0.01 | ||||
| 2016-09-02 |
|
4 | NXEO |
Nexeo Solutions, Inc.
Common Stock |
J - Other | -17,500 | 31,127,844 | -0.06 | ||||
| 2016-09-02 |
|
4 | NXEO |
Nexeo Solutions, Inc.
Common Stock |
J - Other | -17,500 | 31,127,844 | -0.06 | ||||
| 2016-09-02 |
|
4 | NXEO |
Nexeo Solutions, Inc.
Common Stock |
J - Other | -47,500 | 31,180,344 | -0.15 | ||||
| 2016-06-27 |
|
4 | TIPT |
TIPTREE FINANCIAL INC.
Common Stock |
S - Sale | -5,596,000 | 0 | -100.00 | 6.50 | -36,374,000 | ||
| 2016-06-20 | 3 | NXEO |
Nexeo Solutions, Inc.
Common Stock |
62,455,688 | ||||||||
| 2016-06-20 | 3 | NXEO |
Nexeo Solutions, Inc.
Common Stock |
62,455,688 | ||||||||
| 2016-06-20 | 3 | NXEO |
Nexeo Solutions, Inc.
Common Stock |
62,455,688 | ||||||||
| 2016-06-20 | 3 | NXEO |
Nexeo Solutions, Inc.
Common Stock |
62,455,688 | ||||||||
| 2016-06-20 | 3 | NXEO |
Nexeo Solutions, Inc.
Common Stock |
62,455,688 | ||||||||
| 2016-03-04 |
|
4 | SABR |
Sabre Corp
Common Stock |
S - Sale | -13,106,693 | 45,856,647 | -22.23 | 27.25 | -357,157,384 | 1,249,593,631 | |
| 2016-02-19 |
|
4 | TMHC |
Taylor Morrison Home Corp
Class A Common Stock |
P - Purchase | 129,600 | 1,499,732 | 9.46 | 13.19 | 1,708,932 | 19,775,766 | |
| 2016-02-19 |
|
4 | TMHC |
Taylor Morrison Home Corp
Class A Common Stock |
P - Purchase | 52,732 | 1,370,132 | 4.00 | 13.01 | 686,017 | 17,824,732 | |
| 2016-02-19 |
|
4 | TMHC |
Taylor Morrison Home Corp
Class A Common Stock |
P - Purchase | 150,000 | 1,317,400 | 12.85 | 13.24 | 1,985,640 | 17,439,214 | |
| 2016-02-16 |
|
4 | TMHC |
Taylor Morrison Home Corp
Class A Common Stock |
P - Purchase | 20,005 | 1,167,400 | 1.74 | 12.39 | 247,900 | 14,466,304 | |
| 2016-02-16 |
|
4 | TMHC |
Taylor Morrison Home Corp
Class A Common Stock |
P - Purchase | 7,395 | 1,147,395 | 0.65 | 11.95 | 88,394 | 13,715,042 | |
| 2016-02-16 |
|
4 | TMHC |
Taylor Morrison Home Corp
Class A Common Stock |
P - Purchase | 500,000 | 1,140,000 | 78.12 | 11.90 | 5,948,050 | 13,561,554 | |
| 2016-02-11 |
|
4 | ZBH |
ZIMMER BIOMET HOLDINGS, INC.
Common Stock |
S - Sale | -2 | 7,351,710 | 0.00 | 91.37 | -196 | 671,726,478 | |
| 2016-02-10 |
|
4 | TMHC |
Taylor Morrison Home Corp
Class A Common Stock |
P - Purchase | 210,000 | 640,000 | 48.84 | 11.97 | 2,514,687 | 7,663,808 | |
| 2016-02-10 |
|
4 | TMHC |
Taylor Morrison Home Corp
Class A Common Stock |
P - Purchase | 250,000 | 430,000 | 138.89 | 11.51 | 2,876,600 | 4,947,752 | |
| 2016-02-10 |
|
4 | TMHC |
Taylor Morrison Home Corp
Class A Common Stock |
P - Purchase | 180,000 | 180,000 | 11.23 | 2,021,598 | 2,021,598 | ||
| 2016-01-07 |
|
4 | SABR |
Sabre Corp
Common Stock |
J - Other | -18,341,794 | 58,963,340 | -23.73 | ||||
| 2015-12-14 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -4,319,537 | 8,794,282 | -32.94 | 43.27 | -186,914,573 | 380,545,291 | |
| 2015-12-09 |
|
4 | FSL |
Freescale Semiconductor, Ltd.
Common Stock |
D - Sale to Issuer | -27,835,926 | 0 | -100.00 | ||||
| 2015-11-12 |
|
4 | SABR |
Sabre Corp
Common Stock |
S - Sale | -21,361,659 | 77,305,134 | -21.65 | 29.05 | -620,556,194 | 2,245,714,143 | |
| 2015-10-27 |
|
4 | PACE |
Pace Holdings Corp.
Class F Ordinary Shares |
J - Other | -250,000 | 11,090,000 | -2.20 | ||||
| 2015-09-18 |
|
4 | PACE |
Pace Holdings Corp.
Warrants |
P - Purchase | 22,000,000 | 22,000,000 | 0.50 | 11,000,000 | 11,000,000 | ||
| 2015-08-12 |
|
4 | SABR |
Sabre Corp
Common Stock |
S - Sale | -13,518,417 | 98,666,793 | -12.05 | 26.70 | -360,941,734 | 2,634,403,373 | |
| 2015-08-12 |
|
4 | SCAI |
Surgical Care Affiliates, Inc.
Common Stock |
S - Sale | -4,000,000 | 12,156,480 | -24.76 | 37.68 | -150,720,000 | 458,056,166 | |
| 2015-08-12 |
|
4 | IMS |
IMS Health Holdings, Inc.
Common Stock |
S - Sale | -12,563,176 | 110,731,840 | -10.19 | 31.17 | -391,594,196 | 3,451,511,453 | |
| 2015-06-30 | 3 | ZBH |
ZIMMER BIOMET HOLDINGS, INC.
Common Stock |
14,703,424 | ||||||||
| 2015-06-30 | 3 | ZBH |
ZIMMER BIOMET HOLDINGS, INC.
Common Stock |
14,703,424 | ||||||||
| 2015-06-30 | 3 | ZBH |
ZIMMER BIOMET HOLDINGS, INC.
Common Stock |
14,703,424 | ||||||||
| 2015-06-30 | 3 | ZBH |
ZIMMER BIOMET HOLDINGS, INC.
Common Stock |
14,703,424 | ||||||||
| 2015-06-26 |
|
4 | NONE |
LVB Acquisition, Inc.
Common Stock |
J - Other | -536,034,330 | 0 | -100.00 | ||||
| 2015-05-28 |
|
4 | SABR |
Sabre Corp
Common Stock |
S - Sale | -19,632,690 | 112,185,210 | -14.89 | 25.16 | -493,860,317 | 2,822,018,958 | |
| 2015-05-14 |
|
4 | COLL |
COLLEGIUM PHARMACEUTICAL, INC
Series D Convertible Preferred Stock |
C - Conversion | -8,333,333 | 0 | -100.00 | ||||
| 2015-05-14 |
|
4 | COLL |
COLLEGIUM PHARMACEUTICAL, INC
Common Stock |
P - Purchase | 100,000 | 1,325,253 | 8.16 | 12.00 | 1,200,000 | 15,903,036 | |
| 2015-05-14 |
|
4 | COLL |
COLLEGIUM PHARMACEUTICAL, INC
Common Stock |
C - Conversion | 1,207,729 | 1,225,253 | 6,891.86 | ||||
| 2015-05-14 |
|
4 | IMS |
IMS Health Holdings, Inc.
Common Stock |
S - Sale | -9,446,510 | 123,295,016 | -7.12 | 27.09 | -255,882,340 | 3,339,753,746 | |
| 2015-05-14 |
|
4 | IMS |
IMS Health Holdings, Inc.
Common Stock |
S - Sale | -26,967,858 | 132,741,526 | -16.89 | 26.68 | -719,367,612 | 3,540,880,206 | |
| 2015-05-11 |
|
4 | FSL |
Freescale Semiconductor, Ltd.
Warrants |
X - Other | -9,534,587 | 0 | -100.00 | ||||
| 2015-05-11 |
|
4 | FSL |
Freescale Semiconductor, Ltd.
Common Stock |
S - Sale | -8,691,432 | 196,980,050 | -4.23 | 39.62 | -344,354,536 | 7,804,349,581 | |
| 2015-05-11 |
|
4 | FSL |
Freescale Semiconductor, Ltd.
Common Stock |
X - Other | 9,534,587 | 205,671,482 | 4.86 | 36.12 | 344,389,282 | 7,428,853,930 | |
| 2015-04-02 |
|
4 | SCAI |
Surgical Care Affiliates, Inc.
Common Stock |
S - Sale | -7,784,436 | 16,156,480 | -32.52 | ||||
| 2015-03-04 | 3 | TIPT |
TIPTREE FINANCIAL INC.
Class A Common Stock |
11,192,000 | ||||||||
| 2015-03-04 | 3 | TIPT |
TIPTREE FINANCIAL INC.
Class A Common Stock |
11,192,000 | ||||||||
| 2015-03-04 | 3 | TIPT |
TIPTREE FINANCIAL INC.
Class A Common Stock |
11,192,000 | ||||||||
| 2015-03-04 | 3 | TIPT |
TIPTREE FINANCIAL INC.
Class A Common Stock |
11,192,000 | ||||||||
| 2015-03-04 | 3 | TIPT |
TIPTREE FINANCIAL INC.
Class A Common Stock |
11,192,000 | ||||||||
| 2015-03-04 | 3 | TIPT |
TIPTREE FINANCIAL INC.
Class A Common Stock |
11,192,000 | ||||||||
| 2015-02-12 |
|
4/A | SABR |
Sabre Corp
Common Stock |
S - Sale | -19,391,108 | 131,817,900 | -12.82 | 20.02 | -388,281,729 | 2,639,482,084 | |
| 2015-02-11 |
|
4 | SABR |
Sabre Corp
Common Stock |
S - Sale | -19,391,108 | 131,817,900 | -12.82 | 20.02 | -388,281,729 | 2,639,482,084 | |
| 2014-11-26 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
S - Sale | -1,300,000 | 2,087,466 | -38.38 | 25.97 | -33,761,000 | 54,211,492 | |
| 2014-09-25 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
J - Other | 6,244 | 23,663,397 | 0.03 | ||||
| 2014-08-19 |
|
4 | OTIC |
Otonomy, Inc.
Series D Preferred Stock |
C - Conversion | -348,041 | 0 | -100.00 | ||||
| 2014-08-19 |
|
4 | OTIC |
Otonomy, Inc.
Series C Preferred Stock |
C - Conversion | -1,199,695 | 0 | -100.00 | ||||
| 2014-08-19 |
|
4 | OTIC |
Otonomy, Inc.
Series B Preferred Stock |
C - Conversion | -439,724 | 0 | -100.00 | ||||
| 2014-08-19 |
|
4 | OTIC |
Otonomy, Inc.
Series C Preferred Stock |
C - Conversion | 68,259 | 1,199,695 | 6.03 | ||||
| 2014-08-19 |
|
4 | OTIC |
Otonomy, Inc.
Warrant to Purchase Shares of Preferred Stock |
C - Conversion | -68,259 | 0 | -100.00 | ||||
| 2014-08-19 |
|
4 | OTIC |
Otonomy, Inc.
Common Stock |
P - Purchase | 171,875 | 2,159,335 | 8.65 | ||||
| 2014-08-19 |
|
4 | OTIC |
Otonomy, Inc.
Common Stock |
C - Conversion | 1,987,460 | 1,987,460 | |||||
| 2014-07-24 |
|
4 | ROKA |
Roka BioScience, Inc.
Series E Preferred Stock |
C - Conversion | -5,577,814 | 0 | -100.00 | ||||
| 2014-07-24 |
|
4 | ROKA |
Roka BioScience, Inc.
Series D Preferred Stock |
C - Conversion | -6,844,627 | 0 | -100.00 | ||||
| 2014-07-24 |
|
4 | ROKA |
Roka BioScience, Inc.
Series C Preferred Stock |
C - Conversion | -4,030,224 | 0 | -100.00 | ||||
| 2014-07-24 |
|
4 | ROKA |
Roka BioScience, Inc.
Series B Preferred Stock |
C - Conversion | -12,400,000 | 0 | -100.00 | ||||
| 2014-07-24 |
|
4 | ROKA |
Roka BioScience, Inc.
Series A Common Stock |
C - Conversion | -3,880 | 0 | -100.00 | ||||
| 2014-07-24 |
|
4 | ROKA |
Roka BioScience, Inc.
Common Stock |
P - Purchase | 350,000 | 2,989,282 | 13.26 | ||||
| 2014-07-24 |
|
4 | ROKA |
Roka BioScience, Inc.
Common Stock |
C - Conversion | 2,638,753 | 2,639,282 | 498,819.09 | ||||
| 2014-07-24 |
|
4 | CDNA |
CareDx, Inc.
Series G-1 Preferred Stock |
C - Conversion | -462,898 | 0 | -100.00 | ||||
| 2014-07-24 |
|
4 | CDNA |
CareDx, Inc.
Series G Preferred Stock |
C - Conversion | -727,727 | 0 | -100.00 | ||||
| 2014-07-24 |
|
4 | CDNA |
CareDx, Inc.
Series F-1 Preferred Stock |
C - Conversion | -1,187,372 | 0 | -100.00 | ||||
| 2014-07-24 |
|
4 | CDNA |
CareDx, Inc.
Series E-1 Preferred Stock |
C - Conversion | -647,947 | 0 | -100.00 | ||||
| 2014-07-24 |
|
4 | CDNA |
CareDx, Inc.
Series D-1 Preferred Stock |
C - Conversion | -750,750 | 0 | -100.00 | ||||
| 2014-07-24 |
|
4 | CDNA |
CareDx, Inc.
Series C-1 Preferred Stock |
C - Conversion | -2,800,000 | 0 | -100.00 | ||||
| 2014-07-24 |
|
4 | CDNA |
CareDx, Inc.
Common Stock |
P - Purchase | 115,000 | 1,075,090 | 11.98 | ||||
| 2014-07-24 |
|
4 | CDNA |
CareDx, Inc.
Common Stock |
C - Conversion | 960,090 | 960,090 | |||||
| 2014-07-17 |
|
4 | EPRS |
EPIRUS Biopharmaceuticals, Inc.
Common Stock |
J - Other | 22,239,223 | 22,239,223 | |||||
| 2014-07-17 | 3 | EPRS |
EPIRUS Biopharmaceuticals, Inc.
No securities beneficially owned |
0 | ||||||||
| 2014-07-16 | 3 | ROKA |
Roka BioScience, Inc.
Series B Common Stock |
1,058 | ||||||||
| 2014-07-16 | 3 | ROKA |
Roka BioScience, Inc.
Series B Common Stock |
1,058 | ||||||||
| 2014-07-16 | 3 | ROKA |
Roka BioScience, Inc.
Series B Common Stock |
1,058 | ||||||||
| 2014-07-16 | 3 | ROKA |
Roka BioScience, Inc.
Series B Common Stock |
1,058 | ||||||||
| 2014-07-14 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
S - Sale | -488,820 | 2,596,420 | -15.84 | 37.60 | -18,379,632 | 97,625,392 | |
| 2014-07-11 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
S - Sale | -500,000 | 3,387,466 | -12.86 | 25.28 | -12,640,000 | 85,635,140 | |
| 2014-07-11 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
S - Sale | -500,000 | 3,887,466 | -11.40 | 25.05 | -12,525,000 | 97,381,023 | |
| 2014-06-30 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
J - Other | 6,044 | 23,657,153 | 0.03 | ||||
| 2014-05-14 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Series D Preferred Stock |
C - Conversion | -2,112,861 | 0 | -100.00 | ||||
| 2014-05-14 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Series C Preferred Stock |
C - Conversion | -11,574,074 | 0 | -100.00 | ||||
| 2014-05-14 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 2,488,533 | 2,488,533 | |||||
| 2014-04-17 | 3 | SABR |
Sabre Corp
Common Stock |
302,418,016 | ||||||||
| 2014-04-17 | 3 | SABR |
Sabre Corp
Common Stock |
302,418,016 | ||||||||
| 2014-04-17 | 3 | SABR |
Sabre Corp
Common Stock |
302,418,016 | ||||||||
| 2014-04-17 | 3 | SABR |
Sabre Corp
Common Stock |
302,418,016 | ||||||||
| 2014-04-11 |
|
4 | IMS |
IMS Health Holdings, Inc.
Common Stock |
S - Sale | -14,290,613 | 159,709,384 | -8.21 | 19.10 | -272,950,708 | 3,050,449,234 | |
| 2014-04-03 | 3 | IMS |
IMS Health Holdings, Inc.
Common Stock |
347,999,994 | ||||||||
| 2014-04-03 | 3 | IMS |
IMS Health Holdings, Inc.
Common Stock |
347,999,994 | ||||||||
| 2014-04-03 | 3 | IMS |
IMS Health Holdings, Inc.
Common Stock |
347,999,994 | ||||||||
| 2014-04-03 | 3 | IMS |
IMS Health Holdings, Inc.
Common Stock |
347,999,994 | ||||||||
| 2014-04-03 | 3 | IMS |
IMS Health Holdings, Inc.
Common Stock |
347,999,994 | ||||||||
| 2014-03-27 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
J - Other | 6,834 | 23,651,109 | 0.03 | ||||
| 2014-02-20 |
|
4 | GPK |
GRAPHIC PACKAGING HOLDING CO
Class A Common Stock |
S - Sale | -12,885,934 | 26,507,330 | -32.71 | 9.85 | -126,926,450 | 261,097,200 | |
| 2014-02-18 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -3,823,076 | 13,113,819 | -22.57 | 52.00 | -198,799,952 | 681,918,588 | |
| 2014-02-07 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Series B Preferred Stock |
C - Conversion | -541,634 | 0 | -100.00 | ||||
| 2014-02-07 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Series A Preferred Stock |
C - Conversion | -9,129,063 | 0 | -100.00 | ||||
| 2014-02-07 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
C - Conversion | 3,085,240 | 3,085,240 | |||||
| 2013-12-30 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
J - Other | 6,975 | 23,644,275 | 0.03 | ||||
| 2013-11-26 |
|
4 | GPK |
GRAPHIC PACKAGING HOLDING CO
Class A Common Stock |
S - Sale | -25,600,866 | 39,393,264 | -39.39 | 8.38 | -214,535,257 | 330,115,552 | |
| 2013-11-20 |
|
4 | TNDM |
TANDEM DIABETES CARE INC
Series D Preferred Stock |
C - Conversion | -2,985,519 | 0 | -100.00 | ||||
| 2013-11-20 |
|
4 | TNDM |
TANDEM DIABETES CARE INC
Series C Preferred Stock |
C - Conversion | -937,014 | 0 | -100.00 | ||||
| 2013-11-20 |
|
4 | TNDM |
TANDEM DIABETES CARE INC
Series B Preferred Stock |
C - Conversion | -260,090 | 0 | -100.00 | ||||
| 2013-11-20 |
|
4 | TNDM |
TANDEM DIABETES CARE INC
Common Stock |
C - Conversion | 2,496,194 | 2,496,194 | |||||
| 2013-11-08 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -59,000 | 16,936,895 | -0.35 | 39.68 | -2,341,256 | 672,094,948 | |
| 2013-11-07 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -79,029 | 16,995,895 | -0.46 | 39.78 | -3,144,003 | 676,145,991 | |
| 2013-11-07 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -81,502 | 17,074,924 | -0.48 | 40.61 | -3,309,788 | 693,410,956 | |
| 2013-11-07 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -119,148 | 17,156,426 | -0.69 | 40.72 | -4,851,349 | 698,558,197 | |
| 2013-11-06 |
|
4 | VCYT |
VERACYTE, INC.
Series C Convertible Preferred Stock |
C - Conversion | -3,158,385 | 0 | -100.00 | ||||
| 2013-11-06 |
|
4 | VCYT |
VERACYTE, INC.
Series B Convertible Preferred Stock |
C - Conversion | -4,016,000 | 0 | -100.00 | ||||
| 2013-11-06 |
|
4 | VCYT |
VERACYTE, INC.
Series A Convertible Preferred Stock |
C - Conversion | -7,033,333 | 0 | -100.00 | ||||
| 2013-11-06 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
C - Conversion | 3,551,929 | 3,551,929 | |||||
| 2013-11-06 |
|
4 | SCAI |
Surgical Care Affiliates, Inc.
Common Stock |
S - Sale | -3,007,095 | 23,940,916 | -11.16 | 22.50 | -67,659,638 | 538,670,610 | |
| 2013-11-01 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Series B Preferred Stock |
C - Conversion | -1,111,831 | 0 | -100.00 | ||||
| 2013-11-01 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Series A-3 Preferred Stock |
C - Conversion | -10,864,738 | 0 | -100.00 | ||||
| 2013-11-01 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Series A-2 Preferred Stock |
C - Conversion | -5,000,000 | 0 | -100.00 | ||||
| 2013-11-01 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Series A-1 Preferred Stock |
C - Conversion | -1,000,000 | 0 | -100.00 | ||||
| 2013-11-01 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
P - Purchase | 284,000 | 4,387,466 | 6.92 | ||||
| 2013-11-01 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
J - Other | 508,152 | 4,103,466 | 14.13 | ||||
| 2013-11-01 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
C - Conversion | 3,595,314 | 3,595,314 | |||||
| 2013-10-29 | 3 | NONE |
ASC Acquisition LLC
Membership Units |
276,217,133 | ||||||||
| 2013-10-18 |
|
4 | MGNX |
MACROGENICS INC
Series D-2 Convertible Preferred Stock |
C - Conversion | -390,127 | 0 | -100.00 | ||||
| 2013-10-18 |
|
4 | MGNX |
MACROGENICS INC
Series C Convertible Preferred Stock |
C - Conversion | -19,724,839 | 0 | -100.00 | ||||
| 2013-10-18 |
|
4 | MGNX |
MACROGENICS INC
Series B-1 Convertible Preferred Stock |
C - Conversion | -18,728,346 | 0 | -100.00 | ||||
| 2013-10-18 |
|
4 | MGNX |
MACROGENICS INC
Series D-2 Convertible Preferred Stock |
J - Other | -22,002 | 390,127 | -5.34 | ||||
| 2013-10-18 |
|
4 | MGNX |
MACROGENICS INC
Series D-2 Convertible Preferred Stock |
C - Conversion | 28,753 | 412,129 | 7.50 | ||||
| 2013-10-18 |
|
4 | MGNX |
MACROGENICS INC
Warrants to purchase Series D-2 Convertible Preferred Stock |
C - Conversion | -28,753 | 0 | -100.00 | ||||
| 2013-10-18 |
|
4 | MGNX |
MACROGENICS INC
Common Stock |
C - Conversion | 2,208,762 | 2,208,762 | |||||
| 2013-10-01 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
J - Other | 7,512 | 23,637,300 | 0.03 | ||||
| 2013-09-20 |
|
4 | Q |
Quintiles Transnational Holdings Inc.
Common Shares |
J - Other | -100,000 | 22,436,759 | -0.44 | ||||
| 2013-09-06 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -21,848 | 17,275,574 | -0.13 | 37.58 | -821,037 | 649,207,433 | |
| 2013-09-06 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -125,865 | 17,297,422 | -0.72 | 37.57 | -4,729,163 | 649,921,226 | |
| 2013-09-06 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -112,524 | 17,423,287 | -0.64 | 37.00 | -4,163,939 | 644,746,993 | |
| 2013-09-03 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -97,830 | 17,535,811 | -0.55 | 36.88 | -3,608,411 | 646,799,621 | |
| 2013-09-03 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -13,050 | 17,633,641 | -0.07 | 36.94 | -482,106 | 651,439,599 | |
| 2013-09-03 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -60,960 | 17,646,691 | -0.34 | 37.47 | -2,284,110 | 661,203,865 | |
| 2013-09-03 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
J - Other | -321,050 | 17,707,651 | -1.78 | ||||
| 2013-08-16 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
J - Other | -3,252,329 | 18,028,701 | -15.28 | ||||
| 2013-08-16 |
|
4 | NCLH |
Norwegian Cruise Line Holdings Ltd.
Ordinary Shares |
S - Sale | -2,875,000 | 19,242,334 | -13.00 | 28.78 | -82,751,412 | 553,854,024 | |
| 2013-08-14 |
|
4 | GPK |
GRAPHIC PACKAGING HOLDING CO
Class A Common Stock |
S - Sale | -4,007,963 | 64,994,130 | -5.81 | 8.45 | -33,867,287 | 549,200,398 | |
| 2013-06-28 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
J - Other | 7,388 | 23,629,788 | 0.03 | ||||
| 2013-06-14 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -57,818 | 21,281,030 | -0.27 | 36.67 | -2,119,972 | 780,296,630 | |
| 2013-06-14 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
S - Sale | -79,908 | 21,338,848 | -0.37 | 36.63 | -2,927,158 | 781,676,144 | |
| 2013-06-14 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
J - Other | -529,702 | 21,418,756 | -2.41 | ||||
| 2013-06-05 |
|
4 | GPK |
GRAPHIC PACKAGING HOLDING CO
Class A Common Stock |
S - Sale | -7,581,506 | 69,002,093 | -9.90 | 7.73 | -58,605,041 | 533,386,179 | |
| 2013-05-31 |
|
4 | LPLA |
LPL Financial Holdings Inc.
Common Stock, par value $0.001 per share |
J - Other | -5,011,727 | 21,948,458 | -18.59 | ||||
| 2013-05-15 |
|
4 | Q |
Quintiles Transnational Holdings Inc.
Common Shares |
S - Sale | -3,944,899 | 22,536,759 | -14.90 | 37.80 | -149,117,182 | 851,889,490 | |
| 2013-05-08 | 3 | Q |
Quintiles Transnational Holdings Inc.
Common Shares |
26,481,658 | ||||||||
| 2013-04-15 |
|
4 | TMHC |
Taylor Morrison Home Corp
Put/Call Option (right/obligation to sell) |
X - Other | -11,286,361 | 43,595,623 | -20.56 | ||||
| 2013-04-15 |
|
4 | TMHC |
Taylor Morrison Home Corp
Common Partnership Units and Class B Common Stock |
X - Other | -11,286,361 | 43,595,623 | -20.56 | 20.68 | -233,401,945 | 901,557,484 | |
| 2013-04-15 |
|
4 | TMHC |
Taylor Morrison Home Corp
Put/Call Option (right/obligation to sell) |
S - Sale | -2,142,900 | 11,286,361 | -15.96 | ||||
| 2013-04-02 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
J - Other | 4,223 | 23,622,400 | 0.02 | ||||
| 2013-03-28 |
|
4 | GPK |
GRAPHIC PACKAGING HOLDING CO
Class A Common Stock |
S - Sale | -2,122,821 | 76,583,599 | -2.70 | 6.72 | -14,265,357 | 514,641,785 | |
| 2013-03-28 |
|
4 | GPK |
GRAPHIC PACKAGING HOLDING CO
Class A Common Stock |
S - Sale | -14,152,144 | 78,706,420 | -15.24 | 6.72 | -95,102,408 | 528,907,142 | |
| 2013-02-08 |
|
4 | NTI |
Northern Tier Energy LP
Common Units |
S - Sale | -1,605,000 | 60,922,500 | -2.57 | 23.42 | -37,589,902 | 1,426,835,411 | |
| 2013-01-28 |
|
4 | NCLH |
Norwegian Cruise Line Holdings Ltd.
Ordinary Shares |
J - Other | 22,117,334 | 22,117,334 | |||||
| 2013-01-28 |
|
4 | NCLH |
Norwegian Cruise Line Holdings Ltd.
Ordinary Shares |
J - Other | -1,250 | 0 | -100.00 | ||||
| 2013-01-24 |
|
4 | NTI |
Northern Tier Energy LP
Common Units |
S - Sale | -10,700,000 | 62,527,500 | -14.61 | 23.42 | -250,599,350 | 1,464,425,314 | |
| 2013-01-17 | 3 | NCLH |
Norwegian Cruise Line Holdings Ltd.
Ordinary Shares |
1,250 | ||||||||
| 2012-12-28 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
J - Other | 5,535 | 23,618,177 | 0.02 | ||||
| 2012-12-20 |
|
4 | GPK |
GRAPHIC PACKAGING HOLDING CO
Class A Common Stock |
S - Sale | -1,403,216 | 92,858,564 | -1.49 | 5.80 | -8,135,987 | 538,403,240 | |
| 2012-12-20 |
|
4 | GPK |
GRAPHIC PACKAGING HOLDING CO
Class A Common Stock |
S - Sale | -28,542,316 | 94,261,780 | -23.24 | 6.10 | -174,108,128 | 574,996,858 | |
| 2012-12-20 |
|
4 | GPK |
GRAPHIC PACKAGING HOLDING CO
Class A Common Stock |
S - Sale | -9,354,779 | 122,804,096 | -7.08 | 5.80 | -54,239,944 | 712,030,429 | |
| 2012-12-17 |
|
4 | WNI |
SCHIFF NUTRITION INTERNATIONAL, INC.
Class A Common Stock |
S - Sale | -7,486,574 | 0 | -100.00 | 42.00 | -314,436,108 | ||
| 2012-12-17 |
|
4 | WNI |
SCHIFF NUTRITION INTERNATIONAL, INC.
Class B Common Stock |
S - Sale | -7,486,574 | 0 | -100.00 | 42.00 | -314,436,108 | ||
| 2012-12-10 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Units |
P - Purchase | 5,822,000 | 23,612,642 | 32.73 | 75,686,000.00 | 440,643,892,000,000 | 1,787,146,422,412,000 | |
| 2012-11-14 |
|
4 | NTI |
Northern Tier Energy LP
PIK Units |
M - Exercise | -18,383,000 | 0 | -100.00 | ||||
| 2012-11-14 |
|
4 | NTI |
Northern Tier Energy LP
Common Units |
M - Exercise | 18,383,000 | 73,227,500 | 33.52 | ||||
| 2012-10-02 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
J - Other | 6,198 | 17,790,642 | 0.03 | ||||
| 2012-08-03 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Series E Convertible Cumulative Redeemable Preferred Stock |
C - Conversion | -13,484,444 | 0 | -100.00 | ||||
| 2012-08-03 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
C - Conversion | 13,484,444 | 17,784,444 | 313.59 | ||||
| 2012-08-01 |
|
4 | NTI |
Northern Tier Energy LP
Common Units Right |
D - Sale to Issuer | -2,437,500 | 0 | -100.00 | 14.00 | -34,125,000 | ||
| 2012-08-01 | 3/A | NTI |
Northern Tier Energy LP
Common Units |
54,844,500 | ||||||||
| 2012-07-25 | 3 | NTI |
Northern Tier Energy LP
Common Units |
57,282,000 | ||||||||
| 2012-07-02 |
|
4 | PKY |
PARKWAY PROPERTIES INC
Series E Convertible Cumulative Redeemable Preferred Stock |
J - Other | 6,666 | 13,484,444 | 0.05 | ||||
| 2012-06-15 | 3 | PKY |
PARKWAY PROPERTIES INC
Common Stock |
4,300,000 | ||||||||
| 2012-05-08 |
|
4 | LPLA |
LPL Investment Holdings Inc.
Common Stock |
P - Purchase | -7,250,000 | 26,960,185 | -21.19 | 33.38 | -241,996,300 | 899,898,623 |
